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Abstract 
 
Background: Individuals with head and neck cancer (HNCa) are at an increased risk of 
malnutrition. Therefore, self-administered nutrition screens which attempt to 
address their nutritional concerns may yield benefits for treatment outcomes and 
quality of life (QOL). 
Methods: 34 participants (26 men, 8 women) completed one demographic and two 
QOL surveys, two nutrition self-screening tools, a nutrition assessment and an ease-
of-use questionnaire. Results of the screens were compared to those of the 
assessment, and relationships between QOL, nutrition status, and demographics 
were examined.  
Results: 32.3% of participants were identified as nutritionally compromised. The 
sensitivity and specificity for the PG-SGA SF and Pt-Global Application were found to 
be 81.8% and 100%, and 63.6% and 100%, respectively. Additionally, alterations in 
nutrition status were found to influence QOL.  
Conclusions: Data suggest that self-administered nutrition screens may be a viable 
option which enable proactive identification of nutritional concerns associated with 
HNCa.  
 
Keywords: head and neck cancer, nutrition screening, quality of life, PG-SGA, Pt-
Global, PG-SGA SF 
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CHAPTER 1: INTRODUCTION AND REVIEW OF LITERATURE 
 
Overview 
 
Current statistics regarding the prevalence of cancer indicate that it is one of the 
leading causes of morbidity and mortality in the world (Ferlay et al., 2015). In a review 
performed by Ferlay et al. (2015) it was estimated that approximately 14.1 million 
individuals were diagnosed with cancer in 2012 and 8.2 million deaths resulted from the 
disease. While these numbers are staggering, Ferlay et al. (2015) projects the cancer 
incidence rate to reach above 20 million annually by year 2025. However, one positive 
trend which has been observed in recent years is that cancer survivorship rates are also 
increasing due to improvements in diagnostic tools and treatment effectiveness (Arends 
et al., 2016; Maruvka, Tang & Michor, 2014). Though the cancer may not be completely 
cured, it is slowly being converted into a chronic condition. Thus, quality of life (QOL) 
issues are becoming increasingly relevant for those diagnosed with and treated for 
cancer as these higher incidence and survivorship rates mean more individuals are going 
to be facing these types of challenges (Payakachat, Ounpraseuth & Suen, 2013).  
QOL is a multidimensional construct which has been defined by the World Health 
Organization (WHO) as a state of “…complete physical, mental and social well-being and 
not merely the absence of disease.” How Individuals with cancer feel physically and 
mentally, their functionality, as well as the disease and treatment related side-effects all 
have the potential to influence QOL. It is well documented that individuals with cancer 
generally experience a relatively low QOL due to the many challenges they face during 
treatment and recovery (List et al., 1996; List et al., 1997; Payakachat et al., 2013). Of 
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the multitude of factors which must be considered while treating individuals with 
cancer, maintenance of their nutrition status is a particularly important concern. Though 
malnutrition-related issues in oncology have been reported in clinical medicine 
throughout the 19th century, it was not until Charles Butterworth Jr’s report of 
malnutrition in hospitalized patients in 1974 and Seltzer’s description of nutrition 
screening in 1979 that nutrition associated with cancer began to receive significant 
attention (Butterworth, 1974; Seltzer et al., 1979). However, malnutrition in hospitalized 
settings continues to exist today at alarming rates (Barker, Gout & Crowe, 2011; Giner, 
Laviano, Meguid & Gleason, 1996). This was a topic central to a recent systematic review 
of literature regarding the nutritional status of individuals with cancer performed by Lis, 
Gupta, Lammersfeld, Markman and Vashi (2012) which found that of the 26 articles 
which met their inclusion criteria, 24 of them concluded that better nutrition status was 
associated with better QOL. However, malnutrition remains an under-recognized clinical 
issue in many hospitalized and outpatient populations, including those with cancer. 
Considering the consequences malnourishment can have on treated individuals as well 
as the costs required to address nutrition related concerns once they have progressed to 
later stages, it too regularly goes undiagnosed and untreated (Barker et al., 2011; 
Tappenden et al., 2013).  
Combining common definitions due to the lack of universal agreement, 
malnutrition has been outlined as a subacute or chronic state of nutritional imbalance 
(deficiency or excess), resulting from lack of nutrient intake or impaired nutrient 
metabolism and inflammatory activity, which causes adverse effects on the body, 
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functioning, and clinical outcome (Lochs, Allison, Meier, et al., 2006; Soeters et al., 2008; 
Teitelbaum et al., 2005). The European Society for Clinical Nutrition and Metabolism 
(ESPEN) has further outlined nutritional risk as being the situation where the outcome of 
a disease or treatment has the potential to be influenced by the nutritional and 
metabolic status of the afflicted individual (Kondrup et al., 2003). Individuals diagnosed 
with cancer are particularly susceptible to experiencing malnutrition and various diet-
related problems as a result of the malignant disease, its treatment and the commonly 
experienced side-effects each of these produce (Gupta, Vashi, Lammersfeld, & Braun, 
2011; Lee, Shin, Bae & Lim, 2016; Takenaka et al., 2014). 
The approximate incidence of malnutrition in the cancer population varies 
between 40-80% (Baldwin & Weekes, 2011; Isenring, Bauer & Capra, 2003) and 
prevalence varies between 50-80% (Tong, Isenring & Yates, 2009) depending on factors 
such as cancer type, tumour stage, location, treatment modality and identification 
method (Baldwin & Weekes, 2011; Lis et al., 2012). These numbers take on increased 
importance when one notes that upwards of 20% of individuals with cancer succumb to 
the associated malnutrition itself, as opposed to the malignant disease (Ambrus, 
Ambrus, Mink & Picken, 1975; Ottery, 1996; Wu et al., 2009). These statistics partially 
explain why many individuals with cancer make changes to their eating habits in 
attempts to maintain their health (Maskarinec, Murphy, Shumay & Kakai, 2001). 
Minimum energy and protein intake levels for individuals diagnosed with cancer have 
been outlined by both ESPEN and The American Society on Parenteral and Enteral 
Nutrition (ASPEN) as being 30 to 35 cal/kg and 1.2 to 2.0 grams of protein/kg body 
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weight respectively; however, even when these requirements are met, weight loss and 
malnutrition can still occur (Arends et al., 2006). Possibly a better approach presented 
by Arends et al. (2016) is determining the total energy expenditure of the individual by 
calculating their resting and physical activity energy expenditure levels and then 
calculating intake requirements from these results. However, this would likely be time 
consuming and depend on accuracy of the data collected, calling the practicability and 
reliability into question. Thus, reliable, effective, and practical nutrition services are still 
being searched for in busy clinical settings. Further, Lee et al. (2016) reported in a study 
that 90% of breast and gynecologic cancer survivors called for these nutrition services in 
order to address their nutrition-related concerns, emphasizing their importance. 
Nutritional management is, therefore, an essential component of cancer care. This may 
be particularly true for those diagnosed with a head and neck cancer (HNCa) due to the 
nutrition compromising tendencies of tumours in these locations and the common 
associated treatments.  
HNCa and Compromised Nutrition Status 
 
HNCa comprises malignancies occurring in the upper digestive track such as the 
oral cavity, oropharynx, hypopharynx and larynx (Langius et al., 2013b). Representing 
approximately 4-5% of newly diagnosed cancers every year (Symonds, Deehan, 
Meredith, & Mills, 2012), these types of cancers are the sixth most common worldwide 
with the eighth highest mortality rate (Ferlay et al., 2015; Ganzer, Rothpletz-Puglia, 
Byham-Gray, Murphy, & Touger-Decker, 2015; Jemal et al., 2011). The annual global 
incidence of HNCa is more than 550,000 and results in approximately 300,000 deaths 
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each year (Jemal et al., 2011). The majority of HNCa cases are squamous cell carcinomas, 
however, individuals may still suffer from locoregionally advanced states of the disease 
(Jemal et al., 2008) and traditional treatments often result in various and significant 
functional and psychosocial impairments (List et al., 1997). As such, individuals with 
HNCa face many challenges and their QOL has been shown to deteriorate due to factors 
such as age, socio-economics, tumor location, treatment modality, treatment-related 
toxicity, and other disease specific symptoms (Languis et al., 2013; Penner, 2009; Reeve 
et al., 2016; Terrell et al., 2004; Wells et al., 2016). This is very important as health 
related QOL has been widely associated with the survival and mortality rates of 
individuals with HNCa (Farnebo, Malila, Mäkitie & Laurell, 2016; Karvonen-Gutierrez et 
al., 2008; Osthus, Aarstad, Aarstad & Olofsson, 2011; van Nieuwenhuizen, Buffart, Brug, 
Leemans & Verdonck-de Leeuw, 2015). To address these threats to QOL, individuals with 
HNCa require a variety of supportive care services (Chen et al., 2009; Oskam et al., 
2013). As poor nutrition status has been associated with worse QOL in those with HNCa 
(Barrios, Tsakos, García-Medina, Martínez-Lara & Bravo, 2014) it is crucial that their 
nutrition-related concerns are addressed.  
As a general observation, individuals with HNCa are among the most frequently 
confronted with nutritional and diet-related issues of all cancer subgroups (Chasen & 
Bhargava, 2009; Lees, 1999; Maskarinec et al., 2001). This is because many anatomical 
structures associated with normal nutrient intake have the potential to be impacted by 
the tumour and its treatment (Maskarinec et al., 2001). Though incidence rates vary 
throughout the literature it has been reported that malnutrition may be present in up to 
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as much as 35-80% of the HNCa population again depending on tumour location, 
treatment modality and method of identification (Gupta et al., 2011; Lees, 1999; 
Takenaka et al., 2014). Additionally, eating problems such as dysphagia (difficulty 
swallowing), odynophagia (painful swallowing), xerostomia (salivary gland dysfunction 
causing mouth dryness and potentially reduced salivary flow) and mucositis (painful 
inflammation and ulceration of the mucous membranes lining the digestive tract) are 
common issues before, during and following cancer therapy (Larsson, Hedelin, 
Johansson & Athlin, 2005; Nourissat et al., 2012; Ottosson, Zackrisson, Kjellén, Nilsson & 
Laurell, 2013). Such side-effects of the tumour and its treatment can considerably 
diminish nutrient intake and make maintaining adequate nutrition and hydration 
difficult, subsequently increasing the risk of nutritional deficiency and dehydration 
(Grant & Kravits, 2000). This can result in weight losses which may exceed as much as 
20% of the individual’s pretreatment bodyweight due to metabolic abnormalities, 
increased energy expenditure and reduced dietary intake (Ehrsson, Langius-Eklöf & 
Laurell, 2011; Kubrak, Olson & Baracos, 2013). This significant nutritional decline and 
weight loss is clinically relevant as it has been shown to reduce the effectiveness of 
treatment, impair functionality, reduce QOL, and lower the survival rates of hospitalized 
individuals with HNCa (Farhangfar et al., 2014; Kubrak et al., 2013). Thus, when 
reflecting on the care and QOL of individuals with HNCa more attention must be 
dedicated to considering the impact of nutritional status. These concerns are likely also 
prominent among the outpatient population.  
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Currently, much of the literature related to nutrition in those with HNCa has 
focused on the hospitalized patient population. Thus, the experience of outpatients with 
HNCa has not been well explored. This is concerning as it is likely that they too may 
experience similar nutritional challenges to those of hospitalized individuals. However, 
how different treatment modalities influence the nutritional experience of these 
individuals, as well as examination into the challenges they commonly experience are 
questions which have not received significant attention. If the nutritional concerns of an 
outpatient population are found to be similar to that of their hospitalized counterparts, 
they could be suffering similar impacts to their QOL. Further attention dedicated into 
exploration of the unique challenges the outpatient population faces in regard to their 
nutritional status and how this influences their health and QOL must be pursued. Thus, 
the primary focus of this research was to attempt to identify the nutritional status of 
outpatients with HNCa through implementation of two self-administered nutrition 
screening tools. Specific questions we address in this study include an assessment of the 
reliability of self-administered nutrition screens, examination of the common nutrition 
impact symptoms in the outpatient HNCa population, and how these nutritional 
concerns may influence perceived QOL. 
Lack of a Universal Definition of Malnutrition and Screening Method 
 
 Nutritional deficiencies can have a vast array of consequences for individuals 
with HNCa such as increased infections rates, treatment disruptions and increases in 
morbidity and mortality (Capuano et al., 2008). To overcome these concerns nutritional 
supports may be necessary to meet daily nutritional requirements (Dawson, Taylor & 
   
8 
 
Bragg, 2015). Various efforts have attempted to standardize these nutrition support 
guidelines. Current examples include a Wiki platform that allowed professionals 
worldwide to input their nutritional recommendations for individuals with HNCa (Brown 
et al., 2013), the ‘ESPEN guidelines on nutrition in cancer patients’ (Arends et al., 2016), 
and the American Dietetic Association medical nutrition therapy protocol (“Medical 
nutrition therapy protocols”, 1999). However, despite these various efforts, their effects 
in clinical settings are often impeded due to frequent lack of interest in nutritional 
aspects of cancer care (Arends et al., 2016) as well as the variability in both the content 
and implementation of these guidelines. This lack of clarity makes it difficult to identify 
the most effective methods of nutrition support and intervention for the HNCa 
population (Nugent, Lewis, & O’Sullivan, 2011). 
Despite the lack of guidelines, nutritional concerns can still be addressed through 
adoption of proactive interventions which seek to avert malnutrition-related 
consequences by preventing nutritional declines (Cushen, Power, & Ryan, 2015). 
Currently, screening and assessment tools are used to assess nutritional status in clinical 
settings, including oncology. However, these assessments are complicated by that fact 
that agreement has yet to be achieved on a universally accepted definition of 
malnutrition in the HNCa population (Meijers, van Bokhorst-de van der Schueren, 
Schols, Soeters & Halfens, 2010; Soeters et al., 2008).  
Though experts tend to agree that energy and protein deficiency, as well as 
decreases in fat-free mass are important aspects of the definition, there is less 
consensus regarding the importance of other elements such as the role of functional 
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status and inflammation (Dechaphunkul et al., 2013; Meijers et al., 2010). Even the 
elements which are currently accepted as being important are debated among experts 
regarding the cut-off points at which these factors become significant indicators of 
malnutrition (Meijers et al., 2010). This has complicated the operationalization and 
identification of malnutrition beyond the simple symptoms of involuntary weight loss, 
reduced body mass index (BMI) and nutritional intake (Meijers et al., 2010). Due to this 
lack of agreement, current definitions of what health care professionals consider to 
constitute a diagnosis of malnutrition has varied. ESPEN believes that “malnutrition is a 
state of nutrition in which a deficiency, excess, or imbalance of energy, protein and 
other nutrients causes measurable adverse effects on tissue/body form (body shape, 
size, and composition) and function, and clinical outcome” (Lochs, Allison, Meier, et al., 
2006, p. 182). ASPEN defined malnutrition as “any disorder of nutrition status including 
disorders resulting from a deficiency of nutrient intake, impaired nutrient metabolism, 
or overnutrition” (Teitelbaum et al., 2005, p. 282). In the literature, various other 
definitions have been used, the most common being unintentional weight loss of >10% 
in the last 6 months or >5% in the last 3 months (Gorenc, Kozjek, & Strojan, 2015). In 
addition to these definitions, the National Cancer Institute’s Common Toxicity Criteria 
has outlined different degrees of weight loss; less than <5% as Grade 0; 5%-10% as 
Grade 1; 10-20% as Grade 2; and >20% as Grade 3 (National Cancer Institute, 2005). The 
inconsistencies and lack of agreement among the definitions of weight loss and 
malnutrition is concerning. Only once the pathophysiology of malnutrition is firmly 
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agreed upon can there be generation of an appropriate and accurate definition and 
measurement tool to assess and diagnose the condition (Soeters et al., 2008).  
The current lack of a universal definition of malnutrition makes the formation 
and validation of tools which can accurately identify and assess the condition difficult. 
Until a universal classification of weight loss and malnutrition is identified, there will be 
no common ground from which nutrition screens, assessments and interventions can be 
structured. As this is presently the case, the criteria and methods used to screen for the 
risk of malnutrition in the HNCa population has varied (Thoresen et al., 2013). This has 
resulted in inconsistencies regarding the classification of individuals based on their 
nutritional status (Thoresen et al., 2013) giving rise to the concern of misclassification 
(Elia, Zellipour & Stratton, 2005; Platek, Hertroijs, Nicholson & Parekh, 2015). As a result, 
individuals who require nutritional interventions may be missed and those who receive 
them may be well-nourished. This has consequences for both the individual and the 
healthcare system, decreasing the efficiency and effectiveness of clinical nutrition 
services (Platek et al., 2015). When this lack of guidelines is considered along with other 
current barriers to the implementation of nutrition screens, it is not surprising that 
compliance has been low. Competing duties of healthcare professionals, the lack of 
resources, time restrictions, as well as many other challenges have restricted regular 
nutrition screening (Elia et al., 2005). A reliable nutrition screening tool for the HNCa 
population which could overcome such barriers would be extremely beneficial. Such a 
measure would reduce the potential of misclassification while also enabling early 
identification and intervention, improving treatment outcomes and resource allocation. 
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However, for a nutritional screening tool to be effective for individuals with HNCa, it first 
must accurately assess, either directly or indirectly the main causes of malnutrition 
within this population. This is by no means a simple task as the malnutrition experienced 
by individuals diagnosed with HNCa is often a complicated multifactorial problem. 
Causes of Malnutrition in HNCa Populations 
 
 Unintentional weight loss leading to malnutrition in individuals diagnosed with 
HNCa is a serious and complicated issue. Often, the malnutrition experienced is due to a 
combination of the cancer and its treatment, the resulting side effects and metabolic 
alterations each of these produce, as well as other personal factors (Languis et al., 
2013a; Langius et al., 2016). These factors combine to increase the difficulty of nutrient 
consumption for individuals with HNCa and may subsequently result in abnormal 
metabolic activity such as elevated energy expenditure leading to energy imbalances 
(Arends et al., 2006; Dechaphunkul et al., 2013). The metabolic alterations and dietary 
issues can have synergistic effects on nutrition, increasing nutritional decline. The 
multifactorial and complex nature of the condition makes addressing the nutritional 
deficiency of individuals with HNCa difficult. One factor impairing the nutrition status of 
individuals with HNCa is the tumour itself due both to its anatomical location and the 
potential symptoms it can produce.  
Tumour Related Causes of Malnutrition in HNCa 
 
Tumours of the head and neck can impair oral intake in many ways. Nutrient 
intake impairment often increases with later tumour stages and tumours located in 
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oropharynx/oral cavity leading to greater degrees of weight loss (Bozzetti, 2009; Ehrsson 
et al., 2011; Lønbro, Petersen, Andersen & Johansen, 2016; Ravasco, Monteiro-Grillo, 
Vidal & Camilo, 2003). The tumour’s anatomical location can generate nutrition impact 
symptoms such as nausea and vomiting, increasing malnutrition risk by impairing 
nutrient retention and making achievement of adequate hydration and nutrition difficult 
(Capuano et al., 2010; Grant & Kravits, 2000; Santarpia, Contaldo & Pasanisi, 2011). The 
tumour may also mechanically impede oral intake through symptoms such as dysphagia 
and odynophagia which impair swallowing function (Alshadwi et al., 2013; Jager-
Wittenaar et al., 2011; Santarpia et al., 2011;). 
Dysphagia is often considered one of the most common and disabling nutrition-
related complications resulting from HNCa and its therapy (Chasen & Bhargava, 2009; 
Kubrak et al., 2010). This is particularly true for those with tumours of the oral cavity or 
oropharynx (List et al., 1997; Rinkel et al., 2015). Often the severity of the dysphagia 
experienced is dependent on the size and anatomical location of the lesion, the surgical 
resection and reconstruction, and comorbidities (Chasen & Bhargava, 2009). Severe 
dysphagia can make consumption of various food types difficult, which may significantly 
impact nutrition. Furthermore, as swallowing function declines muscles associated with 
proper swallowing can lose mass which further decreases nutrient intake and increases 
weight loss (Lis et al., 2012). As such, swallowing problems are a particularly important 
nutritional concern for individuals with HNCa.  
Continuous or occasional pain caused by tumours during oral consumption is also 
a common tumour-related problem which may alter or limit oral intake (Larsson et al., 
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2005; Santarpia et al., 2011). Pain has been identified as an important variable during 
treatment as it has been associated with increased functional impairments, depression, 
decreased QOL, psychological distress and aggregate symptom burden (List et al., 1997).  
These nutritional impacts which result from the tumour may result in the 
development of tumour-induced metabolic dysfunction (Fearon, Voss, Hustead & Cancer 
Cachexia Study Group, 2006; Santarpia et al., 2011), leading to symptoms such as 
elevated energy expenditure, skeletal muscle catabolism (the breakdown of muscle 
mass to produce energy) and tumour-induced anorexia (Fearon et al., 2006; Mueller, 
Compher & Ellen, 2011). All of these factors may collectively increase weight loss and 
the corresponding risk of malnutrition. Thus, the tumour itself can lead to significant 
weight loss for individuals with HNCa which is only exacerbated once treatment begins.  
Treatment Related Causes of Malnutrition in HNCa 
 
It is well documented that common treatment modalities for HNCa such as 
radiotherapy, chemotherapy, and surgery have the potential for side-effects which 
cause weight loss and malnutrition. Antineoplastic treatments, especially when 
combined, may increase nutritional demand or cause side-effects which reduce dietary 
intake (Ehrsson et al., 2011; Van Cutsem & Arends, 2005). Surgery can lead to anorexia, 
pain, disfigurement, asthenia (abnormal physical weakness or lack of energy), anxiety, 
depression, xerostomia, and impairments in mastication, swallowing, communication, 
and potentially breathing (Doyle & Keith, 2005; List et al., 1996; List et al., 1997; Miller & 
Bozeman, 2012; Oskam et al., 2013; Payakachat et al., 2013; Penner, 2009). The side-
effects of surgical interventions can influence the ability and willingness of individuals 
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with HNCa to intake nutrition orally which then can result in nutritional declines (List et 
al., 1997; Macqueen & Frost, 1998; Ravasco et al., 2003). 
Other treatment methods such as chemotherapy and radiotherapy commonly 
involve intensive treatment regimens which are associated with elevated metabolic 
rates and increased treatment-related toxicity and complications (Jager-Wittenaar et al., 
2011; Payakachat et al., 2013). The side-effects of these regimens are often the primary 
factors limiting the nutrient intake of individuals with HNCa (Macqueen & Frost, 1998) 
and commonly result in unintentional weight loss (Dawson et al., 2015). This was 
exemplified in a study performed by Langius et al. (2016) which concluded that radiation 
to lymph nodes and higher radiation doses to the primary tumour were predictors of 
increased side-effects and critical weight loss in individuals with cancer. Additionally, the 
treatment field is also an important consideration during HNCa treatment due to its 
potential influences on nutrition. It can cause radiation induced mucositis (an 
inflammatory response of mucosal epithelial cells) which is associated with pain during 
chewing and swallowing, oral bleeding, odynophagia, dysphagia, and mucosal 
ulcerations (Hayward & Shea, 2009; Miller & Bozeman, 2012; Santarpia et al., 2011). This 
can be further exacerbated by the radio-sensitizing drugs administered during cancer 
treatments (Hayward & Shea, 2009). Overall, treatment fields for HNCa can include 
organs and structures important for chewing and swallowing which if altered as a side-
effect of treatment can result in temporary or permanent chewing and swallowing 
dysfunction which may then influence nutrient intake (Alshadwi et al., 2013; Eisbruch et 
al., 2002). This is especially concerning for those individuals with HNCa receiving a 
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combination of radiation and chemotherapy, which increases treatment toxicity 
(Santarpia et al., 2011). 
Increases in treatment toxicity during HNCa treatment has been associated with 
xerostomia, stomatitis (inflammation of oral tissue, mucosa, dentition, and 
periodontium), anorexia, dysgeusia (alterations in taste), anosmia (loss of smell), trismus 
(reduced mobility of the jaw muscles), nausea and vomiting, sore throat, constipation 
(Alshadwi et al., 2013; Chasen & Bhargava, 2009; Hayward & Shea, 2009), fibrosis of 
tissues (including muscle and connective tissue) and possible neurotrauma causing 
dysphagia (Chasen & Bhargava, 2009). These nutritional concerns can have long-lasting 
impacts on individuals treated for HNCa (Payakachat et al., 2013). Consequently, 
individuals with HNCa are not only at risk of malnutrition prior to and during treatment, 
but also throughout the survivorship period.  
The importance of treatment-related nutritional concerns is emphasized by that 
fact that regardless of the individual nutrition impact symptoms present, increases in 
aggregate symptom burden has been shown to further reduce nutrient intake, survival 
rates, and QOL (Capuano et al., 2010; Farhangfar et al., 2014; List et al., 1997; Reeve et 
al., 2016). Hall, Groome, and Rothwell (2000) concluded that 18% of individuals with 
HNCa included in their study died of the increased comorbidity associated with 
treatment and that many of these nutritional concerns remained burdensome for up to 
7.5 years following treatment. Treatment-related concerns may be particularly 
important for individuals with HNCa who are in advanced stages of the disease or 
experiencing limited performance status as both of these factors have been associated 
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with greater aggregate symptom burden (Farhangfar et al., 2014). Thus, it is critical that 
the nutrition-related impacts of treatment be addressed for those with HNCa. If tumour 
and treatment characteristics were the only factors which needed to be considered to 
implement a nutrition management strategy the solution would be straightforward. 
Unfortunately, tumour and treatment characteristics must be considered alongside 
other variables and personal factors specific to the individual being treated for HNCa. 
Objective Personal Factors Causing Malnutrition in HNCa 
 
For a complete description of what causes malnutrition in individuals with HNCa, 
consideration must be given not only to tumour and treatment-related factors, but also 
to personal factors. This latter category includes objective factors such as tobacco and 
alcohol consumption which suppresses appetite and therefore influence nutrition 
(Alshadwi et al., 2013; Hall et al., 2000; Reeve et al., 2016). The risk of malnutrition also 
tends to increase as one ages (Roller, Eglseer, Eisenberger & Wirnsberger, 2016; Stratton 
& Elia, 2005) due to various factors such as poor appetite and dentition, loss of taste and 
smell, gastrointestinal disorders, isolation, poverty, inability to prepare food, confusion, 
and dementia (Hickson, 2006). Conversely, it is also possible for younger individuals to 
experience increased weight loss based on their higher activity levels and energy 
expenditure (Langius et al., 2016) or greater reductions in muscle mass due to functional 
declines associated with treatment (Languis et al., 2016). Additionally, it should also be 
noted that the selected treatment modality can be influenced by age, resulting in 
differing impacts to nutritional status.   
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As older individuals are expected to fare worse during treatment there is greater 
focus placed on supportive aspects of care (Languis et al., 2016). This supportive focus 
can be less present with younger individuals who are expected to better tolerate more 
intense treatment regimens (Reeve et al., 2016; VanderWalde, Fleming, Weiss & Chera, 
2013). The more intense treatments can have consequences for the QOL and nutrition 
status of younger individuals (Reeve et al., 2016; VanderWalde et al., 2013). Overall, it is 
imperative that all individuals with HNCa are informed regarding the likely impacts to 
their nutrition based on their age. This is especially important seeing as those with 
insufficient information tend to experience greater difficulties maintaining weight and 
experience more treatment-related side-effects (Gorenc et al., 2015).  
  Finally, economic factors are often forgotten influencers of nutrition status as 
they can also impact treatment progression, nutrient intake, and QOL (Wells et al., 
2016). This is concerning as individuals treated for HNCa have among the highest risk of 
experiencing disability and ceasing employment, limiting financial income (Liu, 2008; 
Penner, 2009; Taylor et al., 2004). This is a problem as foods high in nutritional value 
tend to be more expensive, causing individuals with limited financial resources to opt for 
the cheaper and less nutritious options. Additionally, cancer treatments and nutritional 
supplements can be expensive (Russell, 2007), which may influence their use if 
individuals lack insurance coverage and are unable to pay out-of-pocket. This would 
have consequences for nutrition status, disease progression, treatment outcome, and 
QOL (Reeve et al., 2016).  
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Subjective Personal Factors Causing Malnutrition in HNCa 
 
Individuals with HNCa are also affected by subjective factors which may impair 
nutrient intake. For example, nutritional status may be negatively affected as the 
individual’s food enjoyment declines (Hayward & Shea, 2009; McQuestion, 2006; Redda 
& Allis, 2006). The symptoms and side-effects experienced during HNCa treatment such 
as xerostomia, suppressed appetite, swallowing difficulty and many others may result in 
increases in the time and effort required to consume food (Gorenc et al., 2015; 
McQuestion, 2006). These difficulties can decrease eating-related QOL as well as one’s 
motivation to consume food orally as eating becomes less enjoyable and more simply 
about survival (Álvarez-Camacho et al., 2016a; Pateman, Ford, Batstone & Farah, 2015).  
As nutrition impact symptoms are common among those treated for HNCa, it is 
not surprising that food aversion is also a common concern in up to 60% of these 
individuals (Chasen & Bhargava, 2009). Meals may become stressful and time-
consuming events due to the extra time devoted to mastication and swallowing; 
individuals also may feel uncomfortable or embarrassed by not being able to eat in ways 
deemed socially acceptable; for example, they may struggle with keeping their mouths 
clean during eating or experience frequent coughing (McQuestion, 2006; Ottosson, 
Laurell & Olsson, 2013; Penner, 2009). These difficulties may impair nutritional intake as 
well as lead to social isolation, exclusion or disruption of relationships with social 
supports, and a hesitance to eat in the presence of others who do not understand their 
situation (Álvarez-Camacho et al., 2016b; Chasen & Bhargava, 2009; List et al., 1996; Ma, 
Poulin, Feldstain & Chasen, 2013; Penner, 2009). This potential impact on one’s social 
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activities results in an increased risk of depression for individuals with HNCa (List et al., 
1996; Van Liew et al., 2017). This emphasizes the impact the emotional burden may 
have on the individual as well as their nutritional status.  
The emotional stress and existential crisis the individual may experience during a 
cancer diagnosis and treatment may reduce nutrient intake, causing nutritional decline 
(Capra, Ferguson & Ried, 2001; Larsson et al., 2005). Thus, the psychological, social, and 
emotional domains of food consumption are also afflicted (Ottosson et al., 2013a; Reeve 
et al., 2016). This subjective concern may be particularly important for younger 
individuals as aggressive treatments are more common, increasing the extent and 
severity of potential comorbidities, psychological impacts, and distress experienced 
(Dawson et al., 2015; Hoffman, McCarthy & Ng, 2008).  
Cancer Cachexia as a Cause of Malnutrition in HNCa 
 
Overall, tumour-, treatment- and personal factors all combine to produce the 
levels of malnutrition that individuals with HNCa experience. The anorexia resulting from 
these nutrition impact symptoms is a serious and multidimensional nutritional issue 
which when combined with the associated metabolic abnormalities can ultimately lead 
to cancer cachexia. Cancer cachexia is a metabolic syndrome which combines anorexia, 
reduced nutrient absorption, appetite and/or diet alterations, hormone-induced 
metabolic changes, weakness, anemia, and edema which is a distinct nutritional 
problem from either simple starvation or chronic malnutrition (Arends et al., 2016; 
Couch et al., 2015; Miller & Bozeman, 2012; Ravasco et al., 2003; Thomas, 2007;). During 
simple starvation and chronic malnutrition metabolic rates tend to adaptively decline 
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with reduced energy intake, whereas cachexia is associated with hypermetabolism 
(Baracos, 2006).  
Cachexia is a complex systemic response to starvation, proinflammatory 
cytokines, and hypermetabolic states caused by the underlying malignant disease, 
negative energy balance, and skeletal muscle wasting which results from reductions in 
nutrient intake (Baracos, 2006; Chasen & Bhargava, 2009; Couch et al., 2015; 
Dechaphunkul et al., 2013; Miller & Bozeman, 2012; Thomas, 2007). The potential 
metabolic alterations associated with cachexia such as hypermetabolism, insulin 
resistance, lipolysis, proteolysis results due to failures in anabolic pathways and 
activation of catabolic ones (Baracos, 2006). This leads to decreases in protein synthesis 
and depletion of physiologic energy and protein reserves at a rate that is greater than 
would be expected based on the food intake rates (Baracos, 2006; Couch et al., 2015). 
These metabolic alterations along with symptoms such as decreased appetite, functional 
impairments, inflammation reducing body cell mass, and fatigue, can greatly impact the 
nutritional status and body composition of the individual and have detrimental effects 
on overall performance status and QOL (Barac-Nieto, Spurr, Lotero & Maksud, 1978; 
Chasen & Bhargava, 2009; Couch et al., 2015; Gorenc et al., 2015). Perhaps most 
importantly and understandably, cachexia has been identified as a condition that is 
associated with high mortality rates (Thoresen et al., 2013). Approximately 20% of 
individuals who succumb to HNCa do so as a result of functional cardiac impairment that 
occurs in response to the wasting of the cardiac muscle associated with cachexia (Couch 
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et al., 2015; Prakash et al., 2010; Der-Torossian, Gourin & Couch, 2012; Tisdale, 2002). 
Thus, cachexia poses threats to nutrition status, QOL, and survival. 
Concerns associated with cancer cachexia are further confounded by the fact 
that conventional nutritional support methods such as nutritional supplements and 
appetite stimulants are unable to fully reverse the weight loss experienced (Baracos, 
2006; Chasen & Bhargava, 2009; Dechaphunkul et al., 2013; Thomas, 2007). This is likely 
why cachexia is associated with greater treatment toxicities and reduced treatment 
tolerance (Couch et al., 2015). Despite the consequences and morbidity generated by 
cancer cachexia, this complex condition is not completely understood.  
Overall, the intertwining effects of the tumour, its treatment and personal 
factors create a multidimensional nutritional problem for which intervention is 
complicated. The fact that so many factors combine to produce the malnutrition 
experienced by individuals with HNCa warrants interprofessional collaboration. The 
implementation of an accurate and standardized screening tool to identify these causes 
of malnutrition could yield significant benefits to both treatment outcomes and QOL. If 
nutritional concerns are continually disregarded aspects of cancer care the 
consequences to the healthcare system and the individuals it cares for could be severe.   
Consequences of Malnutrition in HNCa  
 
The incidence of malnutrition among individuals with HNCa has been estimated 
to be between 35-80% and that nearly 20% of individuals with HNCa die as either a 
direct result of it or its associated consequences, as opposed to solely the cancer (Gupta 
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et al., 2011; Takenaka et al., 2014; Wu et al., 2009). Weight loss of just 5% over six 
months is associated with various side-effects and consequences (Ma et al., 2013). 
Increased mortality, morbidity, fatigue, impaired QOL, impaired immunity, more 
frequent and severe treatment induced toxicities and treatment interruptions, reduced 
treatment response rates, and greater hospital readmission rates are all consequences 
associated with malnutrition (Capuno et al., 2008; Correia & Waitzberg, 2003; Bozzetti, 
2009; Gorenc et al., 2015; Nitenberg & Raynard, 2000). Malnutrition resulting from 
HNCa and its treatment has also been associated with higher rates of insomnia, anxiety, 
depression, psychological distress and reduced physical, role, social, cognitive and 
emotional functioning (Arends et al., 2016; Capuano et al., 2010; Ma et al., 2013; Oskam 
et al., 2013; Schmidt, Olson, Kubrak, Parliament & Ghosh, 2013). Approximately 35-40% 
of individuals with HNCa experience these types of distressing issues over the course of 
their illness and rates increase as nutrition status declines (Ma et al., 2013). Additionally, 
5-year survival rates are inversely proportional to weight loss, illustrating how the 
effects of malnutrition extend into survivorship (Languis et al., 2013a). These symptoms 
and side-effects can contribute to further disease progression and a declining QOL and a 
subset may even result in further impairments to nutritional status. These consequences 
are concerning given that >50% of individuals in advanced stages of HNCa experience 
impaired nutrition and significant involuntary weight loss at diagnosis prior to 
commencing treatment (Chasen & Bhargava, 2009; Larsson et al., 2005; van Leeuwen, 
Sauerwein, Kuik, Snow, & Quak, 1997;). These numbers increase over the treatment 
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period in the absence of nutritional interventions (Chasen & Bhargava, 2009). This can 
result in consequences for the treated individual as well as the healthcare system. 
Past studies have assessed the impact of malnutrition on the healthcare system 
and shown that the average cost of hospitalization is much greater for malnourished 
individuals (Nitenberg & Raynard, 2000). These increased costs of malnutrition are 
indirectly attributable to longer hospital stays, increased resource use (consultations, 
treatments, etc.), higher rates of re-admissions, higher infection rates and poor wound 
healing (Abizanda, Sinclair, Barcons, Lizán & Rodríguez-Mañas, 2016; Correia & 
Waitzberg, 2003; Lim et al., 2012). Groups such as ESPEN and the Alliance to Advance 
Patient Nutrition have expressed their belief that addressing clinical nutritional concerns 
could reduce costs and improve outcomes and QOL (Kondrup et al., 2003; Tappenden et 
al., 2013). Standardized nutrition screening and care could achieve this goal. Thus, the 
routine implementation of guidelines and tools to meet this need is warranted as it 
would result in benefits not only to the individual, but to the healthcare system as well.  
Screening Nutrition Status in HNCa 
 
By definition, screening in medicine is the process of identifying someone at risk 
from a given population of individuals who may not have any obvious signs or symptoms 
(Cayne & Bolander, 1991). Though the risk of malnutrition is expected to be high for 
individuals with HNCa, unless obvious signs are present, it should not be assumed that 
they are at risk until it is proven through nutritional screening. Thus, screening for 
nutritional risk and the making of appropriate referrals for nutrition assessment are 
considered to be fundamental first steps in the nutritional care pathway (Atkins, 
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Basualdo-Hammond, Hotson & Dietitians of Canada, 2010). For hospitalized individuals, 
nutrition screening should be undertaken immediately following admission and at 
regular intervals thereafter, ideally by a nurse in daily contact with them (Arends et al., 
2016; Davies, 2005). Nutrition screens briefly examine characteristics commonly 
associated with nutrition problems through a short survey or questionnaire (typically 
requiring less than 5 minutes) (Lee, Choi, Son & Lyu, 2013, p. 118; Mueller et al., 2011, p. 
16; Zekri et al., 2014). Through screening, those at nutritional risk can be identified to 
undergo further detailed nutrition assessments and, if necessary, interventions. The aim 
of this process is to prevent nutritional declines and long-term nutritional impacts, as 
well as to reduce morbidity and mortality during and following treatment (Arends et al., 
2016; Miller & Bozeman, 2012). Thus, the content, practicability, intended purpose, 
reliability, and predictive and content validity are all important considerations when 
selecting a screening tool in order to ensure the appropriate individuals are being 
identified as nutritionally compromised (Cushen et al., 2015). An efficient screening tool 
which addresses these considerations would be beneficial to clinical care. 
ASPEN has recommended that healthcare institutions generate and approve 
some type of standard nutrition screening process (Ukleja et al., 2010). Additionally, in 
the US, the Joint Commission mandates nutrition screening within 24 hours of admission 
to an acute care center as it is a “Medicare Condition of Participation” (Joint Commission 
International Accreditation Standards for Hospitals, 2013) and, therefore, a requirement 
for accreditation or certification of United States healthcare facilities (Centers for 
Medicare & Medicaid Services, 2003; Skipper, Ferguson, Thompson, Castellanos, & 
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Porcari, 2012). Nutrition screening for individuals with HNCa is in accordance with these 
goals and is a promising means through which nutritional concerns could be addressed.  
Current Situation of Nutritional Screening Tools 
 
Despite the potential benefits of standardized routine nutrition screening, 
compliance to these nutrition evaluations remains low likely due to the lack of interest 
in nutrition-related aspects of care (Arends et al., 2016). Despite nutrition screening 
practices being mandated, there is debate regarding which tool should be used and who 
should be responsible for performing nutrition screens. This lack of agreement has 
complicated the establishment of consistent practices. Various screening tools have 
been promoted, each of which assesses malnutrition slightly differently. Within 
oncology, many of the promoted screens are sophisticated, time-intensive, and require 
skilled personnel to complete (Zekri et al., 2014). As well, different subsets of nutrition 
screening tools have been recommended, including but not limited to, the Nutritional 
Risk Screening 2002 (NRS 2002), Malnutrition Universal Screening Tool (MUST), Mini 
Nutritional Assessment (MNA), Nutritional Risk Index (NRI) and Malnutrition Screening 
Tool (MST) (Gorenc et al., 2015; Jones, 2002; Kondrup et al., 2003; Lis et al., 2012). 
These screening tools have been created to best fit the needs of various healthcare 
settings and professionals, and each has its strengths and weaknesses. However, many 
of these tools were validated using biased processes or underwent insufficient 
evaluations of their effectiveness (Jones, 2002). For example, some tools were validated 
using the same rater to complete the nutrition screen and assessment, introducing 
potential biases (Ferguson, Capra, Bauer & Banks, 1999; Laporte et al., 2015). Other 
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research on nutrition screens has been conducted using trained researchers or 
healthcare professionals which potentially inflates results regarding the accuracy of the 
screening tool in question (Ferguson et al., 1999; Laporte et al., 2015). Resultantly, the 
validity and reliability of these tools is unclear in ‘real-world’ settings where nutrition 
screens are often completed by busy staff with limited training (Laporte et al., 2015).  
As a result of this lack of standardization in nutrition screening, BMI and body 
weight loss are often the primary tools utilized for nutrition screening (DeCicco, 
Wunderlich, & Emmolo, 2011). Although effective indicators in some studies, BMI 
methods have limitations as alone they often fail to indicate important disease or 
therapy-related changes in the individual’s caloric intake and metabolism (DeCicco et al., 
2011; Isenring, Capra & Bauer, 2004). Additionally, the cut-off points for BMI are often 
arbitrary and based on young, healthy adults (Davies, 2005) which may not be 
appropriate for individuals with cancer. Furthermore, it is possible for individuals with 
BMIs of <18.5 to remain well-nourished while malnutrition may be overlooked in those 
classified as normal or overweight (Davies, 2005; Gupta et al., 2011; Isenring, Cross, 
Daniels, Kellett & Koczwara, 2006; Ottosson et al., 2013b; Soeters et al., 2008). Higher 
levels of body fat may mask the loss of lean body mass, leading to unidentified 
malnutrition (Bauer, Capra & Ferguson, 2002; Isenring et al., 2004). Additionally, studies 
have shown that a BMI of >25 is associated with increases in weight loss experienced by 
individuals treated for HNCa (Lønbro et al., 2016). Thus, using BMI as the sole indicator 
of nutrition status is not recommended and additional nutritional screening methods are 
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necessary. However, barriers present in both the healthcare system and current 
screening tools complicate their routine implementation in clinical settings. 
Current Issues Regarding the Implementation of Routine Nutrition Screens 
 
Routine screening for malnutrition has been made mandatory in the UK, US and 
parts of Europe. However, compliance has been low or, as previously indicated, simple 
measurements such as BMI have been used despite their limitations. Routine nutrition 
screening has not been possible due to various challenges such as limited human and 
financial resources and time restrictions (Abbott et al., 2014; Santarpia et al., 2011). It is 
estimated that these nutrition care practices would result in an additional 0.3-2.0 hours 
of professional labour per evaluation (Arends et al., 2016). As clinicians already 
experience heavy workloads, provision of these services often fall to other healthcare 
team members.  
As physicians are unable to regularly provide nutrition services, tasks such as 
nutrition screening is generally carried out by nurses (Green & Watson, 2005). Nurses 
are arguably the most appropriate members of the healthcare team to screen for poor 
nutritional status as they are likely to have more frequent interaction with the 
individuals being screened (Molassiotis & Holmes, 2005). However, nurses themselves 
have outlined various challenges impeding their ability to implement regular nutrition 
screens, such as heavy workloads, their perception that professional judgement is just as 
useful as screening tools for identifying malnutrition, inadequate nutrition screening 
knowledge and training and a lack of awareness of evidence-based nutrition screening 
practices (Raja et al., 2008). This is supported by Martin, van der Schueren, Blauwhoff-
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Buskermolen, Baracos and Gramlich (2014) who identified that the lack of clear 
guidelines for nutrition screens was the main barrier to their routine implementation. 
Without clear guidelines the difficulty of accurately detecting individuals at nutrition risk 
in a standardized manner increases.  
Further barriers to the implementation of nutrition screens identified by Martin 
et al. (2014) included disagreement regarding which tools were most appropriate, 
whose responsibility it was to perform the screens, and what proper protocol was 
following screening. To date, these concerns have posed major challenges to the regular 
completion of nutrition screens in clinical oncology.  
The Ideal Nutritional Screening Tool  
 
The ideal nutrition screening tool would be able to proactively identify 
individuals at risk of malnutrition with 100% sensitivity and specificity. This is, however, 
unlikely an achievable goal. A good screening tool is characterized by both sensitivity 
and specificity of at least 80% (Azad, Murphy, Amos & Toppan, 1999; Platek et al., 2015). 
Sensitivity enables appropriate detection and referral of malnourished individuals, while 
specificity reduces interventions provided to those who are well-nourished and prevents 
unnecessary referrals (Shahar & Hussain, 2007). Though both sensitivity and specificity 
are important, the need to correctly classify all malnourished individuals (tool sensitivity) 
may take precedence (Skipper et al., 2012). ESPEN has further stated that an idealized 
screening tool should be simple, able to be standardized, rapid, non-invasive, and cost-
effective for clinical practice (Kondrup et al., 2003). Additionally, Soeters et al. (2008) 
suggested that nutritional assessments which evaluate nutrient balance, body 
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composition, inflammatory activity, and functionality would provide an accurate 
description of an individual’s nutritional state. Thus, screening tools which incorporate 
similar measurements may also prove effective. However, screening tools should avoid 
calculations and the need for laboratory data as these measures complicate nutrition 
screening (Green & Watson, 2005; Leuenberger, Kurmann & Stanga, 2010). Finally, an 
ideal screening tool should be linked to a protocol for action to direct the next steps of 
nutrition care to ensure efficient and effective allocation of resources (Leuenberger et 
al., 2010). Thus, a simple and efficient tool could enable proactive nutrition screening in 
clinical settings and even potentially be self-administered.  
In the clinical literature, it does not appear as though any current tools meet all 
the criteria of an ideal nutrition screening tool, nor have self-administered nutrition 
screening tools been given significant attention. Only minimal work has been done 
assessing the application of self-administered nutritional screens in clinical settings. If 
proven accurate and effective, such screens could yield unique benefits. Self-
administered nutrition screens can be rapid, simple, reliable, and feasible for clinical 
settings and could facilitate the regular completion of screens (McGurk, Jackson & Elia, 
2013). Given that current nutrition screens have been unable to overcome such 
challenges the potential utility of self-administered nutrition screens deserves further 
exploration. Allowing individuals to facilitate their own routine nutrition screens would 
enable them to become advocates for the maintenance of their nutrition status, 
ensuring significant attention is given to identifying and addressing nutrition-related 
concerns. Additionally, lack of human resources and heavy workloads of healthcare 
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professionals would no longer be a barrier as self-administered nutrition screens would 
be completed by the individuals being treated. This proactive approach would enable 
early identification of nutritional concerns which could then be addressed, preventing 
various malnutrition-related consequences and saving both time and money. Therefore, 
it can be argued that an effective self-administered nutrition screening tool would 
significantly benefit the clinical identification, monitoring, and management of 
nutritional concerns associated with cancer. However, it must be noted that despite the 
potential benefits of self-screens, caution must be taken during their implementation as 
there would be concerns regarding their validity and reliability when completed by 
certain populations of individuals (Cawood, Elia, Sharp, & Stratton, 2012).  
When considering concerns regarding the validity and reliability of self-screening 
instruments, attention must be directed to the potential for both over- and under-
reporting. For example, after contemplating their health state, individuals with HNCa 
may become more attentive to factors which could be negatively influencing their 
health and nutrition. Therefore, the potential for over- or under-reporting of such 
variables may in part be dependent on their subjective interpretation of what is clinically 
relevant (McClement, 2005). Additionally, though it is likely a lesser concern for physical 
information, it remains a possibility that for a variety of individual reasons patients may 
conceal this physical information. Recall bias may also lead an individual to misreport 
screen information as various factors can influence an individual’s ability to recall 
information (Coughlin, 1990). Thus, the added potential for bias and the occurrence of 
either over- or under-reporting means that unintentional misreporting is an ongoing 
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concern. Careful thought must be dedicated to assessing how these concerns may 
present in specific populations of patients and how they can be accounted for.  
Finally, the ideal nutrition screening instrument will have considered how the 
prevalence rates of malnutrition may influence positive and negative predictive values. 
This is because different cancer types, even different HNCa subgroups, are associated 
with differing prevalence rates of nutritional concerns (Arends et al., 2016; Zekri et al., 
2014). Thus, the same tool will have differing predictive values dependent on the 
prevalence rates of malnutrition in the particular patient population; positive predictive 
values tend to increase with increasing prevalence rates, while negative predictive 
values decrease. Conversely, with decreasing prevalence rates, positive predictive values 
tend to decline while negative predictive values increase. Predictive values and how they 
vary depending on the prevalence of nutritional concerns are important considerations 
for healthcare providers. These values inform healthcare providers of the likelihood of a 
patient with a positive result having the disease as well as one with a negative result not 
having the disease. Thus, the psychometric properties of any screening tool and how 
these can be influenced by prevalence rates must always be considered.   
Assessment of Nutritional Status in HNCa 
 
Any individual identified as at risk of malnutrition following a nutrition screen, 
should undergo a complete assessment by a qualified professional (Davies, 2005; 
Leuenberger et al., 2010; Meijers et al., 2010; Soeters et al., 2008). Nutritional 
assessments provide an accurate definition of an individual’s nutritional status and a 
foundation for future nutritional monitoring and interventions (Arends et al., 2016; 
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Cushen et al., 2015; Ottosson et al., 2013a). Such measures aim to improve clinical 
outcomes by addressing malnutrition when it presents, improve QOL, and reduce 
adverse effects of anticancer treatments (Arends et al., 2016; Cushen et al., 2015). 
Methods of Nutrition Assessment 
 
Various nutrition assessments have been utilized within the cancer population, 
each with strengths and weaknesses. Often the circumstances will dictate which method 
of assessment is used, but inclusion of both objective and subjective parameters is 
common. Nutrition assessments are laborious and comprehensive examinations of 
nutritional concerns which combine nutrition information, past medical histories, 
physical examinations, anthropometric measurements, and laboratory data (Mueller et 
al., 2011). However, these assessment tools are not used at admission to hospital to 
assess nutrition due to their complexity and the lack of resources needed for their 
completion (Isenring et al., 2006; Smith, Smith, Ledgard, Doig, & Chesher, 2009). Thus, a 
preference for less laborious nutritional assessment tools has emerged. Current 
nutritional assessment methods commonly used for individuals with cancer include the 
Subjective Global Assessment (SGA) and the Patient Generated-SGA (PG-SGA). Though 
both are comprehensive nutrition assessments, the PG-SGA, developed by Ottery et al., 
was validated specifically for assessing the nutritional status of individuals with cancer. 
SGA Nutrition Assessment 
 
The SGA is a simple, cost-effective and easy-to-apply nutritional assessment tool 
with fair-to-good predictive validity recommended by the ASPEN board of directors for a 
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variety of patient groups (Gupta et al., 2011; Lis et al., 2012; Shirodkar & Mohandas, 
2005; Platek, et al., 2015; van Bokhorst-de van der Schueren, Guaitoli, Jansma & de Vet, 
2014). The SGA includes a comprehensive assessment completed by a healthcare 
professional of symptoms which can influence nutritional intake, functionality and 
physical capacity, dietary intake, and gastrointestinal symptoms (Lim et al., 2013). The 
SGA also includes a physical examination of any muscle wasting, fat depletion, and 
nutrition-related edema (Lim et al., 2013). Overall, the SGA is patient-centered, 
incorporates the clinical history of the individual, and does not require laboratory testing 
or medical imaging exams, easing its implementation (Gupta et al., 2011; Wakahara et 
al., 2007). However, for SGA assessments to be reliable, they are required to be 
performed by trained personnel and the grading depends on the accurate reporting of 
the histories and physical observations of the individual being assessed (Wakahara et al., 
2007). This rigorous process has resulted in professional resistance to the regular 
performance of the SGA upon hospital admittance (Leuenberger et al., 2010). Moreover, 
the SGA is not sensitive enough to detect short-term changes in nutrition status (Bector, 
Vagianos, Suh & Duerksen, 2016). Thus, the SGA has more often been used as a 
reference standard against which other nutrition screening tools have been evaluated 
(Cushen et al., 2015; Platek et al., 2015). Despite the positives of the SGA, it has inherent 
limitations and also is not specific to individuals with cancer, leading to the 
consideration of other assessment tools such as the PG-SGA. 
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PG-SGA Nutrition Assessment 
 
The Nutrition Dietetic Practice Group of the American Dietetic Association has 
promoted the PG-SGA as the gold standard for nutritional assessments in oncology 
(Gorenc et al., 2015). Many studies have also promoted the PG-SGA and it is commonly 
utilized as a standard which other nutritional assessments and screens have been 
evaluated against (Abe Vicente, Barão, Silva & Forones, 2013; Beck et al., 2015; Kim et 
al., 2011). The PG-SGA is a simple tool adapted from the SGA and developed for 
individuals with cancer. It has proven to be a sensitive, specific, and reliable tool for 
predicting nutrition status as defined by the SGA (Cushen et al., 2015; Gorenc et al., 
2015; Gupta et al., 2011). The PG-SGA consists of a self-completed assessment of the 
individual’s histories (weight, food intake, symptoms, and functioning) and a clinician 
assessment of the metabolic demands of the disease, its impact on nutritional 
requirements and a physical examination (Gorenc et al., 2015). Thus, the PG-SGA 
enables quick nutrition assessments and allows the clinician to spend more time 
addressing problems rather than gathering information (Gupta et al., 2011).  
The PG-SGA utilizes two scoring methods. The continuous scoring method allows 
for prioritization of those individuals in need of more urgent care, effectively allocating 
limited resources, while the PG-SGA global rating scores (A, B, or C) give an overall 
depiction of the individual’s nutrition status (Bauer et al., 2002; Gupta et al., 2011). 
These scores are then linked to triage recommendations to guide the next steps of the 
nutrition care process. Overall, the PG-SGA is less time intensive then the SGA, identifies 
a more extensive range of nutrition impact symptoms and incorporates a scoring system 
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which enables prioritization of individuals in most urgent need of care and effective 
resource allocation (Bauer et al., 2002). For these reasons the PG-SGA has been the 
most studied, validated, and commonly accepted nutrition assessment method for 
individuals with cancer (Boléo-Tomé, Monteiro-Grillo, Camilo, & Ravasco, 2012; Cushen 
et al., 2015). However, the PG-SGA still relies on the literacy of the individual performing 
the assessment, is considered to be time-consuming, and requires examiner training 
(Leuenberger et al., 2010). As such, the routine implementation of the PG-SGA in clinical 
settings remains limited as there is neither time nor resources to regularly apply this 
tool. It would, therefore, seem that the only way to ensure every individual who needs a 
nutritional assessment receives one is to have assessments preceded by screens. Though 
all individuals with HNCa would still undergo nutrition screens, only those identified as 
being at nutritional risk would undergo the laborious and comprehensive nutritional 
assessments, effectively utilizing and allocating limited human and financial resources.  
Statement of Problem 
 
Though various screening tools currently exist and have been used in oncology 
settings, there has been little consistency in their clinical application and the compliance 
to nutrition screening practices. The absence of a universal definition for malnutrition 
makes it difficult to determine which screening tool produces the most accurate 
classification of the problem (Isenring, & Elia, 2015; Meijers et al., 2010). This has meant 
that the number of individuals identified as being at nutrition risk has depended on the 
screening tool utilized, making comparisons between studies difficult. Without standard 
nutrition guidelines regarding the identification of individuals at nutritional risk, the 
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provision of nutritional interventions and how we monitor and follow-up will continue to 
vary. Additionally, without clear guidelines, compliance to nutritional care practices in 
oncology may remain low due to healthcare professionals lack of confidence in 
malnutrition identification protocols (Spiro, Baldwin, Patterson, Thomas & Andreyev, 
2006). This may result in the nutritional concerns of some individuals going 
unrecognized in certain healthcare settings. Furthermore, healthcare resources are not 
likely to be allocated to this important issue as long as the prevalence of malnutrition 
varies based on the method used to identify it (Platek et al., 2011). This is especially true 
for the outpatient HNCa population, a group that is currently underrepresented in 
literature, as their nutritional concerns and challenges may be less apparent.  
Without sensitive and specific screening tools, nutritional complications may 
worsen. Though validated and more accurate nutrition assessment methods are 
available such as the SGA and the PG-SGA, their routine implementation is impractical. It 
is, therefore, important that alternative nutrition evaluation methods be explored such 
as self-administered nutrition screens. Implementation of such screening tools could be 
a step towards ensuring that every individual in need of nutrition care services receives 
them. Consequently, the proposed study sought to improve the maintenance of the 
nutritional status of outpatient individuals with HNCa by increasing compliance to 
nutrition screening through validation of two self-administered nutrition screening tools 
for this population. The self-screening tools selected were the PG-SGA short form (PG-
SGA SF) and the Pt-Global Application. These tools were compared to the PG-SGA to 
assess their sensitivity, specificity and predictive values. Other objectives included the 
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gathering of information on individual ability to perform self-screens as well as the 
presence and extent of malnutrition-related concerns in the HNCa population and their 
impacts on QOL.   
Significance of Project 
 
The literature promotes early and proactive nutritional interventions as these 
cost-effective strategies prevent malnourishment more successfully than approaches 
delayed until later stages of excessive weight loss (Baracos, 2006; Isenring, Bauer & 
Capra, 2007; Langius et al., 2016; Prevost, Joubert, Heutte, & Babin, 2014; Ravasco, 
Monteiro Grillo & Camilo, 2008; Uster et al., 2013). Additionally, studies have presented 
conflicting conclusions regarding how interventions such as nutrition supplementation 
(Baldwin & Weekes, 2012) and nutrition counselling (Arends et al., 2016; Platek, 2012;) 
influences mortality rates, weight changes and energy intake when delayed until later 
stages of treatment as the effectiveness of such methods depends on compliance to 
nutritional regimens. Tube feeding, on the other hand, only inconsistently yields benefits 
for individuals with cancer (Huhmann & August, 2009; Paleri & Patterson, 2010). It has 
been associated with decreases in their willingness to consume food orally which can 
result in muscle atrophy and late swallowing difficulties, leading to further nutritional 
declines and reduced QOL (Paleri & Patterson, 2010; Reeve et al., 2016; Terrell et al., 
2004; Wells et al., 2016). Thus, nutritional interventions must be initiated early in order 
to be most effective (Bloch, 2000; Capra et al., 2001; Piquet et al., 2002; Prevost et al., 
2014). The costs and risks associated with delaying nutrition interventions until later 
stages of treatment outweigh the inconsistent benefits they produce. Standardized 
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nutrition screening practices could enable proactive approaches for addressing 
nutritional concerns and reduce the need for costlier and less effective nutrition 
interventions later on. 
Standardizing clinical nutrition screening has been outlined as a top priority of 
the Canadian Malnutrition Task Force (Laporte et al., 2015). Standardized screens able 
to overcome challenges associated with current screening tools would be beneficial in 
terms of efficiency, safety, healthcare and QOL (Abbott et al., 2014; Lim et al., 2012; 
Tappenden et al., 2013). A valid and efficient self-administered nutrition screening tool 
for the outpatient HNCa population with acceptable sensitivity and specificity would 
achieve this goal (Abbott et al., 2014; Larsson et al., 2005; Tappenden et al., 2013). 
Additionally, the cost savings of nutritional screening protocols have been estimated to 
be around $217 million annually according to Barents Group of KPMG Peat Marwick LLP 
(1996), which has been supported by other studies (David, Bernstein & Coifman, 2013). 
Thus, improving nutrition care practices for those at nutritional risk has been identified 
as the fourth largest potential cost saving initiative by the National Institute for Health 
and Care Excellence (2013). Cost savings of up to $1,500 per malnourished individual 
have been identified in recent studies (Somanchi, Tao & Mullin, 2011). Though screening 
practices may result in minor cost increases initially, these costs would be justified and 
counteracted by reduced clinical expenses incurred attempting to correct the 
malnutrition-related consequences individuals with HNCa experience later on (Abizanda 
et al., 2016; Correia & Waitzberg, 2003; Norman, Pichard, Lochs, & Pirlich, 2008). 
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Therefore, not only does screening benefit QOL and overall healthcare, but it can greatly 
reduce healthcare expenditures.  
However, as long as compliance to nutritional evaluations remains low, whether 
due to the lack of efficient and validated screening tools or lack of standard nutrition 
guidelines, proactive management of nutritional concerns will be difficult. Nutrition 
evaluations in the oncology population will continually be overlooked or performed 
inappropriately or too late. To prevent malnutrition and its associated consequences, 
the development of new methods enabling routine nutrition screens are warranted 
(Isenring et al., 2004; Tappenden et al., 2013). This is especially important in situations 
where malnutrition is deemed to have high prevalence, such as in the HNCa population.  
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CHAPTER 2: METHOD 
 
Participants 
 
The population utilized in this study included both adult men and women 
diagnosed with and treated for HNCa. Participants were between the ages of 30 and 80 
years. The mean age of all participants was 61.8 (SD= 10.02).  Of those who participated, 
there were 26 males who had a mean age of 60.12 (SD=9.92, range 42 - 79 years) and 8 
females who had a mean age of 67.375 (SD=9.47, range 50 - 80 years).  
This study identified 37 individuals as potential participants of which 35 
consented. The two participants who opted not to consent indicated that they were 
unable enroll in the study due to time restrictions. Of the individuals who initially 
consented to participate 32 completed the study on site while three selected to 
complete the study at home and return it by mail. Of the three individuals who took the 
package off-site, one male did not return it. Overall, complete study data were obtained 
for 34 individuals (26 males and 8 females) resulting in a participation rate of 91.9% 
(89.7% and 100% response rates for males and females, respectively). All participants 
had been diagnosed with HNCa with exclusion of those with skin cancers. 
Comprehensive demographic information of all participants is presented in Table 1.  
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Table 1. Participant Demographic Information 
Demographic Information, N=34 
  
Treatment Information 
  
  
Male, n= 
26, (76.5%) 
Female, n= 
8, (23.5%) 
Cancer Site 
  
Age - Mean (SD) 
60.116 
(9.92) 
67.375 
(9.47) Oral Cavity 15 (44%) 
Married/ 
Partnered 18 (69%) 5 (62.5%) Larynx 11 (32.25%) 
Current/Former 
Alcohol 
consumption 23 (88.5%) 7 (87.5%) Thyroid 3 (8.75%) 
Current/Former 
Tobacco 
consumption 21 (81%) 7 (87.5%) Pharynx 5 (15%) 
Occupational Status Treatment Modality 
Working 10 (38.5%) 2 (25%) Surgery alone 16 (47%) 
Volunteer 0 0 
Surgery and 
radiation  8 (23.5%) 
Retired 11 (42%) 6 (75%) 
Surgery, radiation 
and chemotherapy 4 (11.75%) 
Other 5 (19%) 0 Other 6 (17.75%) 
Highest Level of Education Completed 
Average Number of Months Since 
Diagnosis 
Completed High 
School 7 (27%) 2 (25%) <6 Months 6 (17.75%) 
Some college/ 
post-secondary 5 (19%) 2 (25%) 6- <12 Months 4 (11.75%) 
Completed 
college/ post-
secondary 8 (31%) 1 (12.5%) 12- <18 Months 2 (5.75%) 
Graduate 
Program 2 (7.5%) 1 (12.5%) 18- <24 Months 4 (11.75%) 
Other 4 (15.5%) 2 (25%) 24- >24 Months 18 (53%) 
Household Income ($) 
Average Number of Months Since 
Treatment Completion 
<25,000 3 (11.5%) 1 (12.5%) Not yet completed 3 (8.75%) 
25,000-50,000 6 (23%) 1 (12.5%) <6 Months 7 (20.5%) 
50,001-75,000 2 (7.5%) 2 (25%) 6- <12 Months 5 (15%) 
>75,000 7 (27%) 3 (37.5%) 12-<18 Months 4 (11.75%) 
Prefer not to say 8 (31%) 1 (12.5%) 18-24 Months 15 (44%) 
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Initial Identification of Potential Participants  
 
Primary physicians identified potential participants during the patient’s regular 
clinical appointment at the London Health Sciences Centre, Victoria Campus, located in 
London, Ontario. During this initial contact, the physician briefly outlined the purpose of 
the study to the potential participant and referred them to the primary researcher if 
they expressed interest in obtaining additional information and potentially participating. 
The primary investigator then provided a complete description of the study as well as 
full details regarding study involvement, including the risks, benefits, and potential 
outcomes. Once individuals had been fully informed, they were asked if they would like 
to consent to participating in the study. Upon written confirmation of consent patients 
were given a letter of information, a support services contact list, a demographic 
information sheet (Appendix C), two QOL surveys (the EORTC-QLQ-C30 and the EORTC-
QLQ-H&N35), two self-administered nutrition screens (the PG-SGA SF and the patient 
completed portion of the Pt-Global App), and an ease-of-use questionnaire. Participants 
also were asked to complete a PG-SGA nutrition assessment, including a brief non-
invasive physical exam administered independently by a physician. Prior to commencing 
the research and gathering of data from participants, ethical approval was obtained 
from Western University’s Health Sciences Research Ethics Board (Appendix A). 
Inclusion Criteria  
 
As noted, all potential participants had to be between the ages of 30 and 80 
years, were outpatients diagnosed and/or being treated for HNCa regardless of 
treatment modality, and were between 3 months post-diagnosis and 24 months post-
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treatment. In order to be included in the study, participants were also required by self-
report to be able to read, write, and understand English in order to understand 
instructions, provide informed consent, and complete study tasks.  
Exclusion Criteria  
 
Participants with any form of skin cancer (basal cell, squamous cell, or 
melanoma) were excluded as these cancers should not put a patient at an increased risk 
of nutritional decline (Britton et al., 2016; Brown et al., 2013). Participants outside the 
pre-determined age range or who were less than 3 months post-diagnosis or more than 
24 months post-treatment also were excluded. Participants who were unable to read or 
speak English were excluded as they may have experienced difficulty completing the 
tasks necessary for the study. For similar reasons participants with severe physical 
disabilities, dementia or other obvious cognitive impairments, or those who indicated 
that their vision did not permit them to see the questionnaires were also excluded.   
Measurement Instruments 
 
Patient Generated – Subjective Global Assessment (PG-SGA) version 3.22.15 
 Prior to using this measure, written permission was obtained from its developer 
(Dr. Ottery and the Pt-Global team at info@pt-global.org). These researchers are the 
copyright holders of the PG-SGA, thus, approval was sought to utilize this nutritional 
measurement tool through completion of the online permission form. The main purpose 
for completion of this form is to maintain records regarding the usage of the PG-SGA.  
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The PG-SGA comprises an assessment of the patient’s self-generated medical 
histories (weight, food intake, symptoms, and activities and function) and a professional 
assessment (including patient diagnosis, age, metabolic stress, and physical exam). The 
PG-SGA utilizes a continuous scoring system, enabling the triaging and prioritization of 
patients requiring more urgent treatment (Bauer, et al., 2002) as well as a Global 
Assessment (categorizing patients as A= well-nourished, B= moderately malnourished or 
suspected malnutrition, or C= severely malnourished). The PG-SGA yields a score from 
“0” (no need for nutrition intervention) to “50” (immediate nutrition intervention 
required). In the oncology setting a minimum score of one is assigned due to the 
presence of the malignant disease while scores greater than or equal to nine indicate 
critical need for symptom management and/or nutritional intervention. Prior research 
has indicated that scores of 9 or greater have been identified as appropriate cut-offs for 
the initiation of urgent nutrition intervention (Bauer et al., 2002). 
The patient completed portion of the PG-SGA consists of 4 boxes regarding the 
individual’s medical histories (Appendix F). In Box 1 (Weight) and Box 3 (Symptoms) 
scores are additive and the final score is recorded. In Box 2 (Food intake) and Box 4 
(Activities and Function) only one option corresponding to a particular score is selected 
and recorded. The remaining portion of the PG-SGA is completed by a professional 
(Appendix F). Box 5 (Disease and its relation to nutritional requirements) and Box 6 
(Metabolic Demand) scores are additive while Box 7 (Physical Exam) is not. Box 7 is a 
subjective rating of the total body deficit through a brief non-invasive physical exam. 
The physical exam assesses three components of body composition (muscle, fat, and 
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fluid status) for their degree of deficit. Subjective ratings given to each of these physical 
components include “0” (no abnormality), “1+” (mild), “2+” (moderate), and “3+” 
(severe). Based off of these subjective ratings an overall score for the entire physical 
exam is given ranging from “0” (no malnourishment) to “3+” (severe malnourishment). 
The PG-SGA has been accepted by the Oncology Nutrition Dietetic Practice Group 
of the American Dietetic Association as the gold standard for nutrition assessment for 
those with cancer (Bauer et al., 2002). In a study conducted by Bauer et al. (2002) the 
PG-SGA was shown to have a sensitivity of 98%, specificity of 82%, and a positive and 
negative predictive value of 95% and 93%, respectively. Additionally, the concurrent 
validity between the PG-SGA and the original SGA was acceptable, with expected 
correlations existing between PG-SGA scores, BMI and percentage weight loss in the 
past six months (Bauer et al., 2002). Further, it was also shown that there was a low 
internal consistency between the seven items of the PG-SGA indicating they were all 
contributing fairly independently to the final scoring. Various studies have confirmed 
that the PG-SGA has acceptable psychometric properties (Ravasco et al., 2003). Thus the 
PG-SGA has demonstrated that it is a simple, efficient, valid and reliable nutrition 
assessment tool which meets psychometric requirements, permitting its use for the 
identification and triaging of malnourished oncology patients in clinical settings. 
Patient Generated – Subjective Global Assessment Short Form (PG-SGA SF)  
The PG-SGA SF, also referred to as the abridged PG-SGA, is entirely self-
completed by the patient. The PG-SGA SF consists of four sections which are identical to 
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the previously described patient completed portion of the current PG-SGA. Thus, the PG-
SGA SF includes four sections which cover the topics of weight history, food intake, 
symptoms, and activity/functionality respectively. The PG-SGA SF utilizes a similar 
continuous scoring system to output a triage score. However, as the professional portion 
of the PG-SGA is not included on the PG-SGA SF, scores are adjusted and can range from 
0 (no nutrition problems) to 36 (severe nutrition problems).  
In studies performed by Gabrielson et al. (2013) and Abbott et al. (2016) the 
validity of the PG-SGA SF has been assessed using heterogeneous groups of oncology 
outpatients. The Gabrielson et al. (2013) study indicated that the PG-SGA SF, using a cut-
off score of equal to or greater than seven to indicate nutritional compromise, yielded a 
sensitivity of 94% and a specificity of 78%. Both studies concluded that the PG-SGA SF 
appears to be a practical and effective nutrition screening tool for identifying nutrition 
risk in oncology patients. However, these studies had heavy focuses on breast, colorectal 
and gastrointestinal cancers and included only very few participants with HNCa. Thus, 
the tools accuracy and sensitivity within the HNCa population when used as a self-screen 
has not been well investigated. Consequently, further investigation into the applicability 
of the PG-SGA SF in the HNCa population would appear to be warranted.  
Pt-Global Application 
The Pt-Global Application launched in 2014. It is a simplified and user friendly 
version of the PG-SGA in an automated format which aims to streamline and increase 
the ease of the nutrition screening process (Ottery et al., 2015). Like the PG-SGA, the Pt-
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Global Application also utilizes a continuous scoring system (0-50) and provides and 
Global Assessment ranking (A, B, or C) which enables the triaging and prioritization of 
patients as well as a summary of their overall nutritional status (Appendix G).  
The Pt-Global Application consists of seven different sections. The first five 
sections are self-completed by the patient. Section 1 (Patient) gathers information 
regarding patient characteristics such as name, age, height and gender. Following this, 
sections 2 through 5 are identical to the first 4 boxes of the PG-SGA and gather 
information regarding weight history, food intake, symptoms, and activity/functionality, 
respectively. The remainder of the Pt-Global App is to be completed by a healthcare 
professional and section 6 (Professional portion) of the Pt-Global Application contains 
three tabs which correspond to boxes 5, 6 and 7 of the PG-SGA. Thus, the remaining 
three tabs examine the diagnosis, metabolic stress, and provides a brief non-invasive 
physical examination. The final section of the Pt-Global Application is the Results section 
where all calculations are completed automatically to yield the PG-SGA triage score and 
overall Global Assessment category ranking. Additionally, colour coding indicates the 
level of concern for each section (i.e., green indicates no concern whereas red indicates 
high concern) and there is a BMI calculation based off of input height and weight.  
Ottery et al. (2015) found that the Pt-Global Application had positive ratings on 
items such as layout, user-friendliness, relevance and appropriateness. It was also found 
that the majority of professionals, researchers, and laypersons who used the application 
over the course of the study considered it appropriate for use in both clinical and 
research settings (Ottery et al., 2015). Given that the Pt-Global App is simply an 
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automated format of the original PG-SGA with a few additional features it is likely that 
the sensitivity, specificity, and positive and negative predictive values will be very similar 
to those of the paper based version of the PG-SGA. 
The European Organization for the Research and Treatment of Cancer Quality 
of Life Questionnaire (EORTC QLQ-C30) 
The EORTC QLQ-C30 is a QOL questionnaire designed specifically for oncology 
populations which covers the physical, emotional and social domains (Appendix D). The 
website for the EORTC group is located at: http://groups.eortc.be/qol. The EORTC QLQ-
C30 was designed to measure an individual’s self-perception of their QOL through a 30-
item questionnaire (Niezgoda & Pater, 1993). The first 28 questions assess symptoms 
commonly reported by the oncology population as well as how these are influencing 
their functioning and QOL. These questions utilize a scale which ranges from 1 to 4. A 
score of “1” means that the indicated symptom is “not at all” influencing the individual’s 
QOL while a score of “4” indicates the symptom is “very much” influencing their QOL. 
Included are 3 symptomatic scales regarding fatigue (3 questions), nausea (2 questions), 
pain (2 questions), 6 single questions evaluating dyspnea, sleeplessness, lack of appetite, 
constipation, diarrhea and financial problems and an assessment of the five functional 
scales: physical (5 questions), role (2 questions), emotional (4 questions), cognitive (2 
questions) and social (2 questions) (Żmijewska-Tomczak et al., 2014). The final two 
questions of the EORTC QLQ-C30 address global perceptions of the individual’s health 
and QOL. These final two questions utilize a scale which ranges from “1” (a “very poor” 
perception) to “7” (an “excellent” perception) (Żmijewska-Tomczak et al., 2014). The 
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EORTC QLQ-C30 has been validated and displayed strong reliability and sensitivity to 
change when assessing the QOL of individuals with different types of cancers including 
head and neck (Bjordal & Kaasa, 1992; Osoba, Zee, Pater, Kaizer, & Latreille, 1994; 
Sherman et al., 2000). 
The European Organization for the Research and Treatment of Cancer Head 
and Neck Cancer Module (EORTC QLQ- H&N35) 
HNCa and common treatment modalities affect a variety of body functions and 
can cause significant physical, emotional and social problems, considerably reducing 
QOL. Therefore, the EORTC QLQ-H&N35 was developed by the EORTC Quality of Life 
Group as a site specific module for the HNCa population (Appendix E). The EORTC QLQ-
H&N35 is a QOL survey which has demonstrated strong reliability, validity and sensitivity 
to change (Bjordal & Kaasa, 1992; Sherman et al., 2000;). It is a site-specific 
questionnaire which assesses concerns commonly reported by individuals with HNCa. 
The EORTC QLQ-H&N35 consists of 35 self-reported items which are divided into seven 
subscales assessing pain (4 questions), swallowing (5 questions), senses (2 questions), 
speaking (3 questions), social contact (4 questions), eating in the presence of others (4 
questions), and sexuality (2 questions) (Żmijewska-Tomczak et al., 2014). Six single 
questions then address issues such as teeth problems, problems opening the mouth, 
dryness of the oral cavity, thick saliva, coughing, and feeling ill (Żmijewska-Tomczak et 
al., 2014). The first 30 questions utilize a scale ranging from 1-4 to assess the influence 
of the examined symptoms on the individual’s QOL. A score of “1” indicates that the 
particular symptom or problem has “not at all” influenced their QOL while a score of “4” 
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indicates that it has “very much” influenced their QOL. The final five questions are 
scored in binary fashion as either “no” (1) or “yes” (2). These questions assess the 
patient’s requirement for pain-killers, nutritional supplements or a feeding tube, as well 
as whether the patient has lost or gained weight (Żmijewska-Tomczak et al., 2014). The 
EORTC QLQ-H&N35 can be used in addition to the EORTC QLQ-C30 when assessing 
symptoms and side effects of treatments influencing the QOL of individuals with HNCa 
(Aaronson et al., 1993; Oskam et al., 2013; Żmijewska-Tomczak et al., 2014).  
Ease-of-Use Questionnaire 
The ease-of-use questionnaire used in this study is designed to assess the 
participant’s perspective regarding their experience with the two self-completed 
nutrition screening tools (PG-SGA SF & Pt-Global Application). The questionnaire consists 
of 12 questions (Appendix F). The first 10 questions utilize a scale ranging from 1 
(strongly disagree) to 5 (strongly agree) and assesses the participant’s impressions 
regarding each of the tools organization, question difficulty, efficiency and simplicity. 
The final two questions are response questions asking participants if they experienced 
difficulties utilizing either tool or whether they had any suggestions for improvements.   
Data Acquisition Procedure 
 
The study population utilized within this project can be considered one of 
convenience. Individuals meeting all inclusion and exclusion criteria were identified and 
asked to participate in the study. Data collection occurred at the London Health Sciences 
Centre, Victoria Campus, London, Ontario between February and May 2017. Those 
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interested in participating in the study received an information letter briefly outlining 
the study and its purpose, ethical guidelines, as well as the potential risks and benefits of 
participation. After confirmation of consent, participants completed the demographic 
survey and the two QOL surveys. Following this the two nutrition self-screening tools 
were administered in a counter balanced manner to prevent the completion order of 
the two screens from inadvertently introducing bias. Then finally, the ease-of-use 
questionnaire was administered to gather patient perceptions regarding their user 
experience with the two nutrition screening tools. 
Participants either completed all self-administered forms on site or, if they were 
unable to complete the forms at that time, took the package with them and returned 
the forms by mail using pre-addressed and pre-stamped envelopes. However, despite a 
portion of the package being able to be completed by study participants at home, the 
nutritional evaluations were required to be completed on site as was the brief and non-
invasive physical exam. This was because the materials required to complete the self-
screens and the physician required to administer the non-invasive physical exam could 
only be found at this location. Remaining information from the professionally completed 
sections of the PG-SGA were gathered by the researcher from charts. In order to 
maintain confidentiality and de-identify personal information, participants were each 
assigned a coded number assuring that they were not able to be personally identified 
over the course of the study; this information was only accessible to the research team. 
Participants were timed and observed as they completed the nutrition self-screens. 
Information obtained from these nutrition self-screens was not disclosed to the 
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professional who administered the PG-SGA nutrition assessment to prevent potential 
bias. The entire process required an average of 21.3 minutes to complete (range = 15 to 
35 minutes). In the case of those who completed the questionnaires outside of clinic, 
the researcher asked the participant to provide the amount of time required for 
completion prior to returning the completed packet of materials to the researcher.  
Data Analysis 
 
Descriptive and Comparative Statistics 
Overall, and as described in earlier sections of this chapter, the study included 
administration of the PG-SGA, the PG-SGA SF, the Pt-Global Application, the EORTC QLQ-
C30, the EORTC QLQ- H&N35, an ease-of-use questionnaire and a demographic survey. 
All participant scores were calculated according to the recommended procedural 
guidelines for each measure. Global QOL, the five functioning scales and the nine 
symptom scales from the EORTC QLQ-C30 were assessed and documented. The 18 
symptom scales from the QLQ-H&N35 were also assessed and recorded. Additionally, 
Global Assessment scores and triaging scores were obtained and recorded from each of 
the nutrition measurement tools, the PG-SGA, the PG-SGA SF and Pt-Global App. 
Descriptive statistics were used to outline and summarize participant characteristics 
such as demographic and tumour/treatment related data. Factors such as gender, age, 
treatment modality, cancer site, marital status, occupational status, educational 
achievement and QOL scores were compared to nutrition status scores through the use 
of comparative statistics. Additionally, comparative statistics were also utilized to 
determine if any correlations existed between the scores obtained from the nutrition 
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measurements and any of the domain scales of the EORTC QLQ-C30 or EORTC QOL-
H&N35. Parametric statistics including t-tests and Pearson correlation coefficients along 
with nonparametric statistics such as Mann-Whitney U tests were performed in order 
evaluate the differences between individuals classified as well-nourished versus 
nutritionally compromised by the PG-SGA nutrition assessment.  
Assessment of Reliability 
The sensitivity, specificity, accuracy, and the positive/negative predictive values 
(PPV/NPV) of the self-administered nutrition screening tools were calculated. Receiver 
operating characteristic (ROC) curves were used to plot and assess the rates of true and 
false positives of the nutrition screening tools compared to the PG-SGA nutrition 
assessment. Briefly, ROC analyses assesses the sensitivity and specificity of a given test. 
An area under the curve on the resulting plot of 1 represents a perfect test while an area 
of 0.5 represents a test which is a poor measure of the given construct. As sample sizes 
in the present investigation were assumed to be adequate, asymptotic significance tests 
were utilized to identify the significance level of results obtained from the ROC analyses. 
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CHAPTER 3: RESULTS 
 
The following sections will present results obtained from the PG-SGA, the 
nutrition screens (PG-SGA SF & Pt-Global Application), the ease-of-use survey, and the 
QOL questionnaires (EORTC QLQ-C30 & EORTC QLQ-H&N35) gathered as part of this 
study. Initially, descriptive statistics including measures of central tendency are reported 
for items completed by participants. Following this, supplementary observational 
analyses were made assessing nutrition trends associated with demographic factors 
such as participant age, treatment modality, and smoking status. 
Comments provided by participants on open-ended questions on both the 
demographic information survey and the ease-of-use survey have also been summarized 
to identify topics/issues which they felt were important. The intention behind this was 
to better our understanding of the experience of individual participants. 
Patient Generated – Subjective Global Assessment (PG-SGA) 
 
Of the 34 participants, 23 (18 males and 5 females) were identified by the PG-
SGA as having good nutrition status (Category A), 9 (6 males and 3 females) had a 
moderately compromised nutrition status (Category B), while 2 males were identified as 
having severely compromised nutrition status (Category C). Thus, nutritional 
complications, classified as either Category B or C, were present in 32.3% of participants 
(30.7% of males and 37.5% of females). Although the majority of participants presented 
as being well-nourished, this does not imply that the remaining nutritional issues that 
emerged were any less concerning. Specifically, for those participants who presented 
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with a compromised nutrition status, many were found to be moderately malnourished 
(M = 11; range 7-17). Detailed participant responses are presented in Table 2.  
Table 2 provides the mean scores calculated for each of the 4 boxes of the 
patient completed portion PG-SGA, as well as for the final professionally completed 
portion. Results have been segregated by nutrition status. It can be seen that the 
nutritionally compromised individuals had higher mean scores than did the well-
nourished individuals on all assessment boxes (indicating a worse nutrition status). The 
greatest difference was observed for box 3 “symptoms influencing nutrient 
consumption”. The most commonly reported nutrition impact symptom identified was 
“dry mouth”, followed closely by “lack of appetite” and an “impaired sense of taste”. 
The least commonly reported nutrition impact symptoms were “vomiting” and an 
“impaired sense of smell”.  
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Table 2. PG-SGA Assessment Score 
Score Summary Nutrition Impact Symptoms 
 WN 
(n=23) 
NC 
(n=11) 
P-Value  WN 
(n=23) 
NC 
(n=11) 
Males 18 8  No Problems Eating 16 
(69.5%) 
1 (9%) 
Females 5 3  No Appetite 0 8 (73%) 
Mean Box 1 0.04 0.36 0.282 Nausea 0 1 (9%) 
Mean Box 2 0.35 1.45 0.019* Constipation 0 2 (18%) 
Mean Box 3 0.52 6 1.78x10-4 * Mouth Sores 0 1 (9%) 
Mean Box 4 0.39 1.36 1.39x10-4 * Funny/No Taste 2 
(8.5%) 
6 
(54.5%) 
Mean Professional 
Score 
1.52 2.18 0.014* Swallowing Problems 3 (13%) 3 
(27.5%) 
Mean PG-SGA 
Score 
2.83 11.36 2.00x10-6 * Pain 0 2 (18%) 
Average Category A B  Vomiting 0 0 
Weight Change in Past 2 Weeks Diarrhea 0 1 (9%) 
Increased 7 
(30.5%) 
4 
(36.5%) 
 Dry Mouth 2 
(8.5%) 
7 
(63.5%) 
Unchanged 15 (65%) 5 
(45.5%) 
 Funny/No Smell 0 0 
Decreased 1 (4.5%) 2 (18%)  Feels Full Quickly 0 5 
(45.5%) 
Food Intake Fatigue 1 
(4.5%) 
4 
(36.5%) 
More than usual 2 (8.5%) 3 
(27.5%) 
 Other 0 1 (9%) 
Unchanged 21 
(91.5%) 
5 
(45.5%) 
 Activities and Function 
 
Less than usual 0 3 
(27.5%) 
 Normal with no limitations 14 
(61%) 
1 (9%) 
Normal food, but 
less than normal 
amount 
4 
(17.5%) 
3 
(27.5%) 
 Not normal self, but able to 
be up and about with fairly 
normal activities 
9 (39%) 6 
(54.5%) 
Little solid food 2 (8.5%) 3 
(27.5%) 
 Not feeling up to most 
things, but in bed or chair 
less than half the day 
0 3 
(27.5%) 
Only nutritional 
Supplements 
0 0  Able to do little activity and 
spend most of the day in 
bed or chair 
0 1 (9%) 
Only liquids 0 1 (9%)  Pretty much bed ridden, 
rarely out of bed 
0 0 
Very little of 
anything 
0 1 (9%)     
Only tube feedings 
or nutrition by vein 
2 (8.5%) 0     
None Selected 15 (65%) 3 
(27.5%) 
    
*Well-Nourished (WN), Nutritionally Compromised (NC). 
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Patient Generated – Subjective Global Assessment Short Form (PG-SGA SF) 
 
Mean scores for the PG-SGA SF were calculated and are presented in Table 3. Of 
the 34 participants, 25 individuals (20 males and 5 females) were identified by the PG-
SGA SF as being well-nourished (Category A), while 9 (6 males and 3 females) were 
identified as being nutritionally compromised (Category B or C). Thus, nutritional 
concerns were present in 26.47% of participants (23.08% of males and 37.5% of females) 
and scores ranged from 0 - 15. For the nutritionally compromised group, the majority 
were moderately malnourished with a mean nutrition score of 10.22. In contrast, those 
identified as being well-nourished had a mean nutrition score of 1.56. The PG-SGA SF 
also agreed with the PG-SGA, identifying “dry mouth” as the most common nutrition 
impact symptom, followed by “lack of appetite” and an “impaired sense of taste” while 
the least common were “vomiting” and an “impaired sense of smell”. On average the 
PG-SGA SF took participants 1.82 minutes to complete.  
Overall, the PG-SGA SF showed good agreement with the PG-SGA and 
demonstrated a sensitivity of 81.8% and a 100% specificity. Additionally, the positive 
predictive value of the PG-SGA SF was 100%, while the negative predictive value was 
92%. A ROC analysis revealed an area under the curve of 0.982 (with lower and upper 
bound score 0.943 and 1.000, respectively). An asymptotic significance test then 
identified an a priori significance level of p=7.0 x 10-6. Further details regarding this ROC 
curve analysis can be found in Figure 1. Thus, the PG-SGA SF demonstrated acceptable 
levels of accuracy as well as a strong ability to predict PG-SGA nutrition scores and 
nutrition category ratings. 
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Table 3. PG-SGA SF Screen Scores 
Score Summary 
  
Nutrition Impact Symptoms 
  
  WN 
(n=25) 
NC 
(n=9) 
P-value   WN 
(n=25) 
NC 
(n=9) 
Males 20 6  No Problems Eating 17 (68%) 0 
Females 5 3  No Appetite 0 8 (89%) 
Mean Box 1 0.04 0.44 0.268 Nausea 0 1 (11%) 
Mean Box 2 0.52 1.22 0.079* Constipation 0 2 (22%) 
Mean Box 3 0.56 7.11 1.20x10-5 * Mouth Sores 0 1 (11%) 
Mean Box 4 0.44 1.44 2.27x10-4 * Funny/No Taste 2 (8%) 6 
(66.5%) 
Mean PG-SGA SF 
Score 
1.56 10.22 3x10-6 * Swallowing Problems 3 (12%) 3 
(33.5%) 
Average Category A B  Pain 0 2 (22%) 
Weight Change in Past 2 Weeks Vomiting 0 0 
Increased 7 (28%) 4 
(44.5%) 
 Diarrhea 0 1 (11%) 
Unchanged 17 
(68%) 
3 
(33.5%) 
 Dry Mouth 3 (12%) 6 
(66.5%) 
Decreased 1 (4%) 2 (22%)  Funny/No Smell 0 0 
Food Intake  Feels Full Quickly 0 5 
(55.5%) 
More than usual 3 (12%) 2 (22%)  Fatigue 2 (8%) 3 
(33.5%) 
Unchanged 22 
(88%) 
4 
(44.5%) 
 Other 1 (4%) 0 
Less than usual 0 3 
(33.5%) 
  Activities and Function 
Normal food, but 
less than normal 
amount 
4 (16%) 3 
(33.5%) 
 Normal with no limitations 15 (60%) 0 
Little solid food 3 (12%) 2 (22%)  Not normal self, but able 
to be up and about with 
fairly normal activities 
9 (36%) 6 
(66.5%) 
Only liquids 1 (4%) 0  Not feeling up to most 
things, but in bed or chair 
less than half the day 
1 (4%) 2 (22%) 
Only nutritional 
Supplements 
0 0  Able to do little activity 
and spend most of the day 
in bed or chair 
0 1 (11%) 
Very little of 
anything 
0 1 (11%)  Pretty much bed ridden, 
rarely out of bed 
0 0 
Only tube feedings 
or nutrition by vein 
2 (8%) 0  Agreement with PG-SGA Assessment 
None selected 15 
(60%) 
3 
(33.5%) 
 Sensitivity 81.8%  
        Specificity 100%  
    Positive Predictive Value 100%  
    Negative Predictive Value 92%  
* Well-Nourished (WN), Nutritionally Compromised (NC). 
   
59 
 
Figure 1. PG-SGA SF Receiver Operating Curve (ROC) 
 
 
Pt-Global Application 
 
Mean scores for the Pt-Global Application were calculated and are presented in 
Table 4. The Pt-Global application identified 7 of 34 study participants (4 males and 3 
females) as being nutritionally compromised (Category B or C), while 27 (22 males and 5 
females) were identified as well-nourished (Category A). Thus, the Pt-Global Application 
identified nutritional complications in 20.6% of participants (15.4% of males and 37.5% 
of females) with scores ranging from 0 - 13. For those who presented with a 
compromised nutrition status, the mean nutrition score was 9.71; those identified as 
well-nourished presented with a mean score of 1.7. The most commonly reported 
nutrition impact symptoms on the Pt-Global application were, “dry mouth” and “lack of 
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appetite”, while the least reported symptoms were “vomiting” and “diarrhea”. On 
average the Pt-Global Application took participants 3.71 minutes to complete. 
Overall, the Pt-Global Application demonstrated fair agreement with the PG-SGA 
demonstrating a sensitivity of 63.6% and a specificity of 100%. Additionally, the positive 
and negative predictive values of the Pt-Global Application were identified to be 100% 
and 85.2%, respectively. Again, an ROC curve analysis was performed which identified an 
area under the curve of 0.962 (with lower and upper bound scores of 0.904 and 1.000, 
respectively). The following asymptotic significant test revealed a significance of p=1.7 x 
10-5. Further details regarding this ROC curve analysis can be found in Figure 2. Thus, the 
Pt-Global Application demonstrated a moderate ability to predict PG-SGA nutrition and 
category ratings, and accuracy ratings all reached acceptable levels with the exception of 
sensitivity which fell below the 80% benchmark value.  
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Table 4. Pt-Global Application Screen Scores 
Score Summary Nutrition Impact Symptoms 
  WN 
(n=27) 
NC 
(n=7) 
P-value   WN 
(n=27) 
NC 
(n=7) 
Males 22 4  No Problems Eating 20 (74%) 1 (14%) 
Females 5 3  No Appetite 1 (3.5%) 6 
(85.5%) 
Mean Box 1 Score 0.04 0.57 6.090 Nausea 0 1 (14%) 
Mean Box 2 Score 0.52 1.14 0.136 Constipation 0 1 (14%) 
Mean Box 3 Score 0.63 6.43 0.002* Mouth Sores 0 1 (14%) 
Mean Box 4 Score 0.52 1.57 0.001* Funny/No Taste 2 (7.5%) 3 (43%) 
Mean Pt-Global 
Score 
1.7 9.71 1.46x10-4 * Swallowing Problems 3 (11%) 2 
(28.5%) 
Average Category A B  Pain 0 2 
(28.5%) 
Weight Change in Past 2 Weeks Vomiting 0 0 
Increased 9 (33%) 2 
(28.5%) 
 Diarrhea 0 0 
Unchanged 17 (63%) 3 (43%)  Dry Mouth 2 (7.5%) 5 
(71.5%) 
Decreased 1 (3.5%) 2 
(28.5%) 
  Funny/No Smell 0 1 (14%) 
Food Intake Feels Full Quickly 1 (3.5%) 3 (43%) 
More than usual 2 (7.5%) 1 (14%)  Fatigue 2 (7.5%) 1 (14%) 
Unchanged 24 (89%) 2 
(28.5%) 
 Other 1 (3.5%) 0 
Less than usual 1 (3.5%) 4 (57%)   Activities and Function 
Normal food, but 
less than normal 
amount 
5 (18.5%) 4 (57%)  Normal with no 
limitations 
15 
(55.5%) 
0 
Little solid food 3 (11%) 0  Not normal self, but able 
to be up and about with 
fairly normal activities 
10 (37%) 4 (57%) 
Only liquids 1 (3.5%) 0  Not feeling up to most 
things, but in bed or 
chair less than half the 
day 
2 (7.5%) 2 
(28.5%) 
Only nutritional 
Supplements 
0 0  Able to do little activity 
and spend most of the 
day in bed or chair 
0 1 (14%) 
Very little of 
anything 
0 1 (14%)  Pretty much bed ridden, 
rarely out of bed 
0 0 
Only tube feedings 
or nutrition by vein 
2 (7.5%) 0  Agreement with PG-SGA Assessment 
None selected 16 
(59.5%) 
2 
(28.5%) 
 Sensitivity 63.6%  
        Specificity 100%  
    Positive Predictive Value 100%  
    Negative Predictive 
Value 
85.2%  
* Well-Nourished (WN), Nutritionally Compromised (NC). 
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Figure 2. Pt-Global Receiver Operating Curve (ROC) 
 
 
Ease-of-Use Survey 
 
The mean, mode, median, range, and standard deviations for the 10 questions 
presented on the ease-of-use survey are summarized in Table 5. Recall that higher 
scores indicate a greater level agreement with the statement. What is clear based on 
these data is that the current participants preferred the PG-SGA SF over the Pt-Global 
Application. Mean scores for all questions asked on the ease-of-use survey were higher 
for those regarding the PG-SGA SF. This indicates that participants were commonly in 
stronger agreement with the statements for the PG-SGA SF than for the Pt-Global 
Application.  
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Table 5. Ease-of-Use Survey Scores 
  N Range Mean Mode Median SD 
PG-SGA SF             
Q1.  Easy to use 34 1-5 4.11 4 4 0.84 
Q2. Organized in 
understandable way 34 1-5 4.29 4 4 0.68 
Q3. Easy to understand 34 1-5 4.29 4 4 0.678 
Q4. Able to be completed 
quickly with ease without 
professional aid 34 1-5 3.97 4 4 1.11 
Q5. Simple tool for assessing 
nutrition status 34 1-5 3.97 4 4 0.834 
Pt-Global App             
Q6.  Easy to use 34 1-5 3.76 4 4 1.13 
Q7. Organized in 
understandable way 34 1-5 4.06 4 4 0.98 
Q8. Easy to understand 34 1-5 4 4 4 0.95 
Q9. Able to be completed 
quickly with ease without 
professional aid 34 1-5 3.76 4 4 1.3 
Q10. Simple tool for assessing 
nutrition status 34 1-5 3.74 4 4 0.99 
 
Results of the EORTC QLQ-C30 
 
The mean, range, and standard deviation scores for each of the 30 questions 
included on the EORTC QLQ-C30 were calculated. These scores were then segregated by 
nutrition status to highlight differences between the QOL scores of the well-nourished 
and nutritionally compromised groups. Items were scaled from 1 (“not at all a problem”) 
to 4 (“very much a problem”). An arbitrary level of significant difference between well-
nourished and nutritionally compromised means was set at 0.5. For both the well-
nourished and nutritionally compromised groups, Question 18 “were you tired” received 
the highest mean score of 1.78 and 2.55, respectively. For the well-nourished group, 
Question 5 “did you need help eating, dressing, washing yourself or using the toilet” 
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received the lowest mean score of 1. This differed from the nutritionally compromised 
group who indicated that Question 15 “have you vomited” was their least concerning 
problem (M = 1). What is important to note is that for every item the score of the 
nutritionally compromised group was either similar to or greater in value when 
compared to the well-nourished group. These scores suggest that the nutritionally 
compromised individuals are having their perceived QOL influenced by these factors to a 
greater degree than the well-nourished group.   
Detailed measures of central tendency for each of the EORTC QLQ-C30 domains 
(Global QOL, physical, role, emotional, cognitive and social functioning, fatigue, nausea, 
pain, dyspnoea, insomnia, appetite loss, constipation, diarrhea and financial difficulties) 
are presented in Table 6; again, these data have been segregated by nutrition status.  
Domain scores could range from 0 (worst possible functioning) to 100 (best 
possible functioning). Well-nourished participants physical functioning revealed the 
highest mean domain score (92.17) while their emotional functioning had the lowest 
mean score (82.25). In contrast, the nutritionally compromised individuals reported that 
their role functioning was best (M = 72.12) while their social functioning was the worst 
(M = 56.06). Most importantly for the present study, significant differences were 
observed between the physical, cognitive and social functioning domains of the well-
nourished and nutritionally compromised groups. In each instance, the perceived QOL of 
the nutritionally compromised group was worse.  
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This trend toward a worse perceived QOL for the nutritionally compromised 
group held true for all the symptoms scale scores as well, with the exception diarrhea 
which was insignificant. Symptom scales also had the possibility to range from 0 (not at 
all a problem) to 100 (very much a problem). Those individuals identified as nutritionally 
compromised also reported experiencing a greater degree of QOL impact on the C30, 
with “fatigue”, “appetite loss”, and “constipation” reaching significance. The symptom 
reported to have the greatest influence on QOL for the nutritionally compromised group 
was “appetite loss” (M = 42.42), while “nausea” was the least influential (M = 4.55). 
 Additionally, the mean Global QOL domain scores for the well-nourished and 
nutritionally compromised groups differed significantly. This revealed that when 
individual perceptions of personal Global QOL were compared, the nutritionally 
compromised group perceived their QOL to be significantly worse.  
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Table 6. EORTC QLQ-C30 Domain/Symptom Scores 
 N Range Mean Median SD P-value 
  WN NC  WN NC WN NC WN NC  
Global Health 
Status          
 
Global QOL 23 11 0-100 78.62 55.3 83.33 58.33 14.5 16.75 3.44x10-4* 
Functional 
Domain Scales          
 
Physical 23 11 0-100 92.17 72.12 93.33 73.33 11.57 17.19 0.001* 
Role 23 11 0-100 86.23 72.73 100 83.33 20.01 32.32 0.155 
Emotional 23 11 0-100 82.25 70.45 83.33 66.67 17.94 22.19 0.124 
Cognitive 23 11 0-100 91.3 63.64 100 66.67 10.85 14.91 4.00x10-6* 
Social 23 11 0-100 86.23 56.06 100 66.67 21.23 32.53 0.003* 
Symptoms/Items           
Fatigue 23 11 0-100 20.29 38.38 22.22 44.44 16.92 19.75 0.016* 
Nausea 23 11 0-100 3.62 4.55 0 0 9.78 10.67 0.808 
Pain 23 11 0-100 18.11 31.82 16.67 33.33 21.93 24.09 0.125 
Dyspnoea 23 11 0-100 11.59 27.27 0 33.33 18.67 31.45 0.087 
Insomnia 23 11 0-100 24.64 30.3 33.33 33.33 28.18 37.86 0.632 
Appetite loss 23 11 0-100 4.35 42.42 0 33.33 11.23 37.11 0.010* 
Constipation 23 11 0-100 4.35 30.3 0 33.33 11.23 36.51 0.048* 
Diarrhea 23 11 0-100 7.25 6.06 0 0 13.75 13.33 0.817 
Financial 23 11 0-100 13.04 33.33 0 0 19.01 43.33 0.175 
* Well-Nourished (WN), Nutritionally Compromised (NC). 
Results of the EORTC QLQ-H&N35  
 
The means, ranges, and standard deviations for the 35 questions of the EORTC 
QLQ-H&N35 were calculated; again, scores were segregated by nutrition status for 
comparison. Scores ranged from 1 (“not at all a problem”) to 4 (“very much a problem”) 
for the first 30 items. An arbitrary level of significant difference between well-nourished 
and nutritionally compromised means was set at 0.5. For the nutritionally compromised 
group Question 7, “have you had problems swallowing solid food?” received the highest 
mean score of 2.91 while Question 4, “have you had a painful throat?”, received the 
lowest mean score of 1.09. Questions 31-35 were excluded from consideration as these 
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questions utilize a different rating scale. Of importance for this study is the finding that 
in every instance where a significant difference was observed between H&N35 items, 
the greater QOL impact was reported by the nutritionally compromised group. 
Detailed measures for each of the symptom domains are summarized in Table 7. 
Symptom domains had the potential to range from 0 (“not at all afflicting”) to 100 
(“completely afflicting”). For the nutritionally compromised group, “dry mouth” 
presented the highest mean score (M = 57.56) while “pain” had the lowest mean score 
(M = 9.8). What is again important to point out is that with exception of “pain”, 
“nutritional supplements” and “weight gain”, none of which achieved significance, all 
H&N35 symptom domain scores received higher ratings from the nutritionally 
compromised group, indicating a greater perceived influence. Significant differences 
were observed between the scores of the “senses” and “speech problems” domains as 
well as the “teeth” and “dry mouth” domains. Additional domains which approached 
significance which had face value for nutrition status were “swallowing”, “trouble with 
social eating” and “social contact” and “sticky saliva”. 
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Table 7. EORTC QLQ-H&N35 Symptom Scores 
 N Range Mean Median SD P-
Value 
  WN NC  WN NC WN NC WN NC  
Symptoms 
scales/items          
 
Pain  23 11 0-100 14.49 9.85 16.7 0 14.79 14.13 0.405 
Swallowing 23 11 0-100 15.22 31.06 8.33 25 22.74 20.13 0.065 
Senses 
problems 23 11 0-100 10.14 42.42 0 50 14.53 28.75 
 
0.005* 
Speech 
problems 23 11 0-100 20.77 40.4 11.1 33.33 23 28.53 
 
0.045* 
Trouble with 
social eating 23 11 0-100 13.41 31.82 0 25 26.89 21.85 
 
0.064 
Trouble with 
social 
contact 23 11 0-100 8.99 28.48 0 20 15.18 27.43 
 
 
0.055 
Less 
sexuality 23 11 0-100 20.29 27.27 0 0 31.83 37.11 
 
0.587 
Teeth 23 11 0-100 14.49 42.42 0 33.33 25.68 32.07 0.012* 
Opening 
mouth 23 11 0-100 11.59 30.3 0 33.33 18.67 33.2 
 
0.120 
Dry mouth 23 11 0-100 24.64 57.56 0 66.67 29.84 35.08 0.010* 
Sticky saliva 23 11 0-100 14.49 33.33 0 33.33 23.73 28.42 0.058 
Coughing 23 11 0-100 24.64 39.39 33.3 33.33 26.41 31.2 0.173 
Felt ill 23 11 0-100 5.8 18.18 0 0 12.63 21.85 0.119 
Pain killers 23 11 0-100 34.78 54.55 0 100 47.63 49.79 0.287 
Nutritional 
supplements 23 11 0-100 30.43 27.27 0 0 46.01 44.54 
 
0.855 
Feeding 
tube 23 11 0-100 13.04 18.18 0 0 33.68 38.57 
0.703 
Weight loss 23 11 0-100 8.7 27.27 0 0 28.18 44.54 0.245 
Weight gain 23 11 0-100 30.43 18.18 0 0 46.01 38.57 0.464 
* Well-Nourished (WN), Nutritionally Compromised (NC). 
Consistency of Responses  
 
Participant’s responses for both EORTC surveys and the nutrition evaluations 
demonstrated consistency. When individuals reported a better perceived global QOL 
and nutrition status, other domains tended to also be rated highly. Conversely, when 
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individuals indicated that the had a lower perceived Global QOL and nutrition status, 
they tended to report a worse perceived functioning and an increased symptom burden. 
Correlation Assessment of Measures 
 
The scores for global QOL, the five functional domains, and 12 of the 27 
symptom scales from both EORTC measures, as well as PG-SGA scores were compared 
to identify potential relationships. This correlational assessment revealed moderate-to-
strong relationships between various measures (Table 8).  
A moderate inverse relationship was identified between the PG-SGA scores and 
the Global QOL scores, r(32) = -0.5, p<0.01. Thus, with increasing nutritional concerns, 
QOL scores tended to decline. Moderate-to-strong relationships were also identified 
between the PG-SGA nutrition scores and many EORTC functional domains, the 
strongest of which was identified for the physical functioning domain, r(32) = -0.63, 
p<0.01. As for the item/symptom scales, the strongest correlations with the PG-SGA 
nutrition scores were found for loss of appetite, r(32) = 0.58, p<0.01, constipation, r(32) 
= 0.56, p<0.01, and senses problems, r(32) =0.6, p<0.01. Remaining values identified by 
the correlational analysis can be found in Table 8.  
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Table 8. Correlation Matrix 
  G- 
QOL 
PG- 
SGA 
 
PF 
 
RF 
 
EF 
 
CF 
 
SF 
 
F 
 
N&V 
 
A 
 
C 
 
S 
 
SP 
 
TSE 
 
T 
 
OM 
 
DM 
 
SS 
 
FI 
Global 
Health  
1 
-
.504** 
.510** .568** .652** .504** .653** 
-
.582** 
-0.092 -.426* 
-
.505** 
-.439** -.473** -.480** -.628** -.394* 
-
.579** 
-.341* 
-
.510** 
PG-SGA 
Score  
 1 
-
.627** 
-0.242 -0.241 
-
.532** 
-
.512** 
.390* 0.111 .582** .564** .401* .599** .443** .395* .368* .437** 0.301 .400* 
Physical    1 .474** .514** 0.335 .498** 
-
.606** 
0.023 -.418* 
-
.673** 
-0.315 -.493** -.399* -.373* -0.066 -.419* -0.275 
-
0.284 
Role     1 .700** .485** .571** 
-
.695** 
-0.107 -.427* 
-
.550** 
-.464** -.374* -.661** -.395* -0.309 -.400* -0.292 -.416* 
Emotional      1 .439** .708** 
-
.789** 
-0.326 -0.162 
-
.457** 
-0.224 -0.215 -.492** -.761** -.376* 
-
.552** 
-0.143 
-
.651** 
Cognitive       1 .450** 
-
.488** 
-0.334 
-
.510** 
-0.284 -.364* -.499** -.374* -.390* 
-
.476** 
-0.323 -0.289 
-
.535** 
Social        1 
-
.525** 
-0.250 -0.291 
-
.505** 
-0.338 -0.189 -.562** -.669** -.344* 
-
.620** 
-0.305 
-
.593** 
Fatigue         1 .375* .483** .564** 0.300 .429* .413* .488** 0.258 .603** .345* .596** 
Nausea & 
Vomiting  
        1 0.223 -0.132 0.257 0.101 0.129 0.072 0.176 0.305 0.187 .730** 
Appetite 
Loss 
         1 .412* .426* .703** 0.223 0.108 .343* .347* .476** 0.323 
Constipation            1 .349* 0.251 .486** 0.283 0.154 .553** .379* 0.236 
Swallowing              1 .464** .709** 0.073 0.328 0.292 .641** 0.320 
Senses 
Problem  
            1 .407* 0.196 .469** 0.175 .411* 0.287 
Trouble 
Social Eating  
             1 0.299 .450** .376* 0.321 .492** 
Teeth                1 .422* .470** 0.007 .428* 
Opening 
mouth  
               1 .393* 0.277 .566** 
Dry mouth                  1 .442** .562** 
Sticky Saliva                   1 0.200 
Felt ill                    1 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Supplemental Observational Analysis of Data  
 
Gender Comparisons  
 
Scores between male and female participants were compared for the Global 
QOL and PG-SGA measures. During these comparisons, statistically significant 
differences were not found between any of these measures based on gender. 
Treatment modality 
The types of HNCa treatments received varied and tended to have an 
influence on the participants’ nutrition status. The first analysis assessed whether 
there was a difference between the nutrition scores of those participants who 
received surgery alone as a treatment (range= 1 – 14) vs. other types of treatment 
such as chemotherapy, radiation therapy or a combined modality (range= 2 - 17). A t-
test indicated that there was a significant difference between groups (t(33)=2.75, 
p<0.01). An additional t-test also indicated a significant difference between the QOL 
of the two groups (t(33)=3.95, p<0.001). Those who received surgery alone had a 
mean PG-SGA score of 3.88, while those who received any other individual treatment 
type or a combination of treatments had a mean PG-SGA score of 7.29. Figure 3 
presents a detailed list of PG-SGA nutrition scores by treatment modality. A Mann-
Whitney U test revealed significant differences for the PG-SGA nutrition assessment 
scores, U(33)=64, p<0.01, across the different treatment modality categories. 
Further, an additional Mann-Whitney U test identified significant differences for 
Global QOL scores, U(33)=48.5, p< 0.01, across treatment modality categories. No 
significant differences between the categories of treatment modality for the variable 
of time post treatment were observed. 
   
72 
 
Figure 3. PG-SGA Scores by Treatment Modality 
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Smoking status  
A t-test was used to identify if there was a significant difference between the 
mean PG-SGA nutrition scores of current and former smokers compared to non-
smokers (6.11 and 3.17, respectively). This test did identify a level of significant 
difference between the two groups (t(33)=2.58, p<0.05). Next current and former 
smoking groups were differentiated (Figure 4). Participants who indicated that they 
had never smoked, tended to have lower PG-SGA scores (range = 1 – 5), while those 
who indicated they were former smokers tended to present with the highest PG-SGA 
scores (range = 1-17) and thus higher nutritional concerns.  
Figure 4. PG-SGA Scores by Smoking Status 
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Age 
A correlational assessment between participant age and PG-SGA assessment 
scores revealed that nutrition scores increased with age (indicating a worse overall 
nutrition status) and this relationship is depicted in Figure 5. The Pearson correlation 
between age and PG-SGA nutrition score was r(32)=0.48, p<0.01. The correlation 
between age and the Global QOL domain scores however, was insignificant.   
Figure 5. PG-SGA Scores by Participant Age 
 
 
Summary 
 
 The present investigation assessed the ability of the PG-SGA SF and Pt-Global 
Application to predict PG-SGA nutrition assessment scores. All accuracy ratings for 
both screening tools achieved the 80% acceptability benchmark with the exception of 
Pt-Global sensitivity. Following this, EORTC scores of those identified as well-
nourished were compared to those identified as nutritionally compromised. Various 
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items achieved significant levels of difference with worse QOL scores reported by the 
nutritionally compromised group. There did prove to be significant correlations 
between nutrition and QOL measures. As nutrition scores increased (greater 
nutritional concerns) QOL ratings decreased, functional domain scores declined, and 
symptom domain scores increased. Finally, significant differences were found to exist 
between the nutrition scores of individuals based on their treatment modality, 
smoking status, and age.   
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CHAPTER 4: DISCUSSION 
 
 The purpose of the present investigation was to assess the accuracy of two 
nutrition self-screening tools when compared to the PG-SGA. This allowed for the 
determination of whether either self-screening tool could be reliably used to 
efficiently and proactively identify individuals at nutritional risk. Additionally, the 
relationship between the nutrition status and QOL of individuals diagnosed and 
treated for HNCa on an outpatient basis was assessed. This study also aimed to 
identify the common nutritional concerns following HNCa treatment. Various 
nutrition impact symptoms, functional domains and the interrelations between the 
two were examined. Thus, the specific questions targeted in this study were: 
1) Are nutritional self-screens able to be reliably completed by outpatients with 
HNCa and are the results comparable to those of nutritional assessments? 
2) What are the commonly reported symptoms impacting the nutrition status of 
individuals with HNCa being treated on an outpatient basis? 
3) What is the relationship between nutrition status and overall QOL among 
individuals diagnosed with HNCa being treated on an outpatient basis? 
Throughout the following sections of this discussion these questions, as well as 
the specific issues that arose from the data obtained will be addressed. This will 
begin with a discussion of the findings gathered from the statistical analyses of the 
PG-SGA nutrition assessment and both nutrition screening tools. This will include 
how the nutrition screens related to the PG-SGA, identification of commonly 
reported nutrition impact symptoms, and how responses differed between the well-
nourished and nutritionally compromised. Following this, results from the statistical 
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analysis of both QOL surveys (EORTC QLQ-C30 and EORTC QLQ-H&N35) will be 
outlined. The relationship between nutritional status and QOL and how the various 
domains differed between well-nourished and nutritionally compromised individuals 
will be discussed. The final sections of this chapter will outline the study limitations, 
the potential clinical implications, and the possible directions for future research into 
self-administered nutrition screening in those with HNCa. 
Patient Generated – Subjective Global Assessment (PG-SGA) 
 
Recall that the PG-SGA was specifically designed to assess the nutritional 
status of individuals with cancer. However, due to limitations such as time 
restrictions and heavy workloads of healthcare professionals, its routine 
implementation has been suggested to be impractical. However, for research and 
comparison purposes it remains a validated nutrition assessment for the cancer 
population (Abe Vicente et al., 2013). 
Based on the PG-SGA nutrition assessment data obtained in the present 
study, the majority of participants identified themselves as having low to moderate 
nutritional concerns. In fact, two-thirds (67.7%) were considered to be well-
nourished while the remaining participants (32.3%) were identified as experiencing 
some degree of nutritional compromise. Therefore, the prevalence of nutrition 
related issues found in the present study is slightly lower than numbers reported in 
past studies of individuals with HNCa (Baldwin & Weekes, 2011; Isenring, Bauer & 
Capra, 2003). This in part may be explained by considering the demographics of our 
study population. Specifically, the present study assessed individuals who were being 
treated on an outpatient basis, many of who were approximately a year post-
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treatment. Further, many participants in the current cohort received surgery as their 
sole treatment modality. These factors all contribute to lower nutrition-related 
concerns. For example, outpatients would be expected to have lower nutritional 
compromise than those individuals who require hospital admittance as their cancer-
related circumstances are likely less severe (Ravera, Bozzetti, Ammatuna, & Radaelli, 
1987; Stratton et al., 2004). Additionally, nutrition impact symptoms are expected to 
decline with time post-treatment as recovery time increases (Isenring et al., 2007). 
Finally, surgical treatments tend to be associated with a lesser degree of nutritional 
compromise than other treatment modalities as its effects tend to be more short-
term (Van Cutsem & Arends, 2005). These trends may offer a possible explanation for 
the lower rate of nutritional compromise reported in the present investigation.  
However, despite lower rates than expected, nutritional concerns were still 
found to exist in 32.3% of our population. Knowing the broad impact that 
compromised nutrition status can have on an individual’s treatment outcome and 
recovery, the finding that one-third of current participants were nutritionally 
challenged is concerning. This emphasizes the need to consider the nutritional 
concerns of outpatients both during and following HNCa treatment. It also should be 
noted that despite the observation of a relatively lower percentage of nutritionally 
compromised individuals when compared to past reports (Gupta et al., 2011; Shaw et 
al., 2014; Takenaka et al., 2014), certain individuals did still experience and reported 
significant nutritional problems. Scores gathered from the PG-SGA assessment 
ranged from 1 – 17 from a possible range of 0 - 50 (M = 5.6) which suggests that 
following diagnosis and treatment for HNCa, an individual’s nutrition status can vary 
greatly; further, one’s status can be influenced by a variety of factors, the most 
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common of which was identified by the present study as being “Dry Mouth”, this 
agrees with past literature (Larsson et al., 2005). Though not all individuals will 
experience nutritional concerns, it would be irresponsible from a healthcare 
perspective to disregard those who are experiencing such problems as they may be 
hindering recovery and functioning (van Leeuwen et al., 1997). Though nutrition 
assessments have inherent limitations which may prevent routine implementation, it 
is possible that self-administered nutrition screening tools may overcome these 
limitations (Cawood et al., 2012). The finding that one third of study participants 
presented with nutrition related concerns justifies exploration into the ability of 
nutrition screening tools to be self-administered in an accurate and reliable manner 
by individuals of the outpatient HNCa population.  
Patient Generated – Subjective Global Assessment Short Form (PG-SGA SF) 
 
Though literature exploring the application of the PG-SGA SF is relatively 
small, there has been a focus on the oncology population. From these studies, the 
PG-SGA SF has proven to be a reliable tool for assessing the nutrition status of 
oncology outpatients with fair-to-good sensitivity and specificity (Abbott et al., 2016; 
Gabrielson et al., 2013). As this tool has proven reliable for a broad cancer 
population, explorations into its applicability in oncology populations where 
nutritional concerns tend to be more severe is warranted, such as in the HNCa 
population. This was assessed through examination of the sensitivity, specificity, and 
positive and negative predictive values of the PG-SGA SF. Scores obtained on the PG-
SGA SF ranged from 0 - 15 (M = 3.85) from a possible range of 0 - 36, results that are 
comparable to those of the PG-SGA. The most commonly reported symptom on the 
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PG-SGA SF was “dry mouth”, a finding that is in agreement with the PG-SGA. Overall, 
the PG-SGA SF identified almost 27% of participants as being nutritionally 
compromised, a similar rate to that of the PG-SGA. This rate is lower than other 
prevelance rates reported in literature of between 35-80% (Gupta et al., 2011; Lees, 
1999; Takenaka et al., 2014) however, recent studies have reported similar rates 
using the PG-SGA SF (Jager-Wittenaar & Ottery, 2017). The resultant sensitivity and 
specificity were 81.8% and 100%, respectively, and the positive and negatively 
predictive values were 100% and 92%, respectively, this again is in agreement with 
past literature (Jager-Wittenaar & Ottery, 2017). Thus, all values reached or 
exceeded cut-off points of above 80% for the PG-SGA SF (Azad, et al., 1999). 
Additionally, averaging 1.82 minutes to complete, the PG-SGA SF was able to be 
quickly self-completed by participants.  
It must be noted, however, that sensitivity, specificity, and negative and 
positive predictive values were expected to be high as the PG-SGA SF is based on the 
original PG-SGA (the PG-SGA SF is identical to the first four boxes of the PG-SGA 
assessment). Ideally, we would hope that any nutritional screen would be able to 
accurately identify malnutrition when present, while at the same time not requiring 
additional evaluation for those not experiencing nutritional deficits. As seen 
throughout this study, however, there were occasions where additional scoring (i.e., 
the professionally completed portion of the PG-SGA) resulted in several individuals 
being identified as nutritionally compromised. Thus, the increased efficiency of the 
PG-SGA SF came at a small expense to its accuracy relative to the PG-SGA 
assessment. However, as previously stated, all values assessing accuracy and 
reliability of the PG-SGA SF reached acceptable levels in the present study (Isenring, 
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Banks, Ferguson, & Bauer, 2012). This warrants further investigation into the use of 
the PG-SGA SF as a self-administered nutrition screening tool. Doing so could provide 
the much needed first step in the nutrition care pathway for these outpatients with 
HNCa. Further, results obtained may provide an efficient and proactive means of 
identifying HNCa outpatients at nutritional risk. Once risk is identified, those 
individuals can then receive comprehensive nutritional assessments to further 
identify problems and potentially lead to intervention.  
Pt-Global Application 
 
 The Pt-Global Application was designed by Dr. Faith Ottery and her team in an 
attempt to streamline and increase the efficiency of the nutrition screening process 
(Ottery et al., 2015). Like the PG-SGA SF, the Pt-Global Application is also based on 
the original PG-SGA. The Pt-Global Application is identical to the PG-SGA except that 
it is in an automated format. This enables the Pt-Global Application to be utilized as 
either a nutrition screening tool (if only patient reported sections are completed) or a 
nutrition assessment tool (both patient and professional reported sections are 
completed). Thus, if utilized for screening purposes, it has the potential to be entirely 
self-completed by patients. The Pt-Global application may increase the efficiency of 
the nutrition screening process by reducing the time required to complete an 
accurate nutrition screen as all calculations and output scores are completed by the 
automated tool. This increased level of efficiency could make the Pt-Global 
application a practical first step in the nutrition care pathway for outpatients with 
HNCa. However, at present there is no information on the utility of the Pt-Global 
Application as a screening tool within the HNCa population. Therefore, one of the 
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aims of the present investigation was to assess whether the Pt-Global Application 
could be used as a nutrition screening tool on an outpatient basis for those being 
treated for HNCa. This was completed by examining the sensitivity and specificity, as 
well as positive and negative predictive values of the Pt-Global Application. 
Pt-Global Application scores obtained ranged from 0 - 13 (M = 3.35) from a 
possible range of 0 - 36, which are slightly lower than the PG-SGA assessment scores. 
The most commonly reported nutrition impact symptoms reported on the Pt-Global 
Application were, “dry mouth” and “lack of appetite”. The finding that “dry mouth” 
was the most commonly reported nutrition impact symptom agreed with results 
obtained by the PG-SGA as well as with past literature (Larsson et al., 2005). 
However, it was reported by fewer individuals on the Pt-Global Application than on 
either of the PG-SGA SF or PG-SGA. This inconsistency between the Pt-Global 
Application and both the PG-SGA SF and PG-SGA may illustrate the potential for 
misreporting when this automated tool is used. Overall, 20.6% of participants were 
identified using the Pt-Global Application as being nutritionally compromised. This is 
slightly lower than the rate reported for the PG-SGA SF, which only differs by mode 
of delivery, and lower than rates reported in the literature (Gupta et al., 2011; Jager-
Wittenaar & Ottery, 2017; Lees, 1999; Takenaka et al., 2014). Additionally, the Pt-
Global Application took slightly longer to complete, averaging 3.71 minutes. These 
findings might be partially explained by examining the results obtained from the 
ease-of-use survey. Our participants reported either no preference between the two 
screening tools, or preferred the paper-based PG-SGA SF nutrition screen. Those who 
preferred the paper-based PG-SGA SF may have been uncomfortable or 
inexperienced with using automated tools such as the Pt-Global Application. Despite 
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this, sensitivity and specificity values of 63.6% and 100%, respectively, were achieved 
by the Pt-Global Application as well as a positive and negative predictive values of 
100% and 85.2%, respectively. Again, these ratings were expected to be high given 
that the Pt-Global Application is based on the original PG-SGA. However, like the PG-
SGA SF, the Pt-Global Application was also not as precise as the PG-SGA assessment 
and was unable to replicate its results with 100% accuracy. 
 The lower scores and decreased accuracy of the Pt-Global Application can 
have consequences for the treatment of those individuals who were nutritionally 
borderline regarding their category rating of A, B, or C, or their triaging 
recommendations output by the tool. The results they received from the Pt-Global 
Application may not have been as serious/urgent as those provided by the more 
thorough PG-SGA assessment. That being noted, the Pt-Global Application still 
managed to achieve acceptable levels of specificity and negative and positive 
predictive values. These psychometric properties are similar to those reported for 
other nutrition screening tools (Jager-Wittenaar & Ottery, 2017; Skipper et al., 2012). 
It is, however, critical to seek a clinical screen that holds the greatest likelihood of 
identifying nutritional problems when they in fact are present, yet also reduces the 
likelihood of misidentification. These findings are believed to warrant its potential for 
use, or at the very least, further investigation into its applicability as a self-
administered nutrition screening tool for individuals of the HNCa population being 
treated on an outpatient basis.  
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Ease-of-Use Survey 
 
The concluding segments the ease-of-use survey included open-ended 
questions where participants could provide additional information. The two final 
questions of the ease-of-use survey addressed any comments/concerns participants 
had regarding each nutrition screening tool used within the present study. Of the 34 
participants, seven provided additional comments which provided an opportunity to 
better our understanding of the participant’s experience with each of the tools.  
The majority of participant comments pertained to the difficulty of using the 
Pt-Global Application without professional assistance. Individuals who are unfamiliar 
using technology and mobile/computer applications may feel uncomfortable using 
the Pt-Global Application. This could potentially lead to misreporting of the 
information required by the Pt-Global nutrition screen, which then could result in 
errors in the final nutrition scores and triaging recommendations. This concern was 
consistent with the data collected within the present investigation. Mean scores for 
all ease-of-use survey questions were higher for the PG-SGA SF when compared to 
the corresponding questions for the Pt-Global Application. This indicates that 
participants were in higher agreement for the statements when they referred to the 
PG-SGA SF. This suggests that participants felt that the PG-SGA SF paper-based 
nutrition screening form was easier to use.  
It is not surprising that a generation which is unfamiliar and less comfortable 
with these types of electronic applications might experience difficulties attempting to 
utilize them in clinical and research settings. As time progresses and the generations 
which grew up using these applications age and begin forming the HNCa population 
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it is possible that the Pt-Global Application may gain favour over a paper-based 
format. However, efforts that assess differences in screening tool preference 
between younger and older demographic groups is needed to determine whether 
this assumption is valid.  
Results of the EORTC QLQ-C30 
 
 The responses provided by study participants to questions of the EORTC 
indicated that the experience of an individual being treated on an outpatient basis 
for HNCa can vary greatly. Though some individuals did not report experiencing any 
symptoms, the majority reported experiencing at least a few of the concerns 
addressed by the EORTC QLQ-C30. Some participants (n = 21) experienced no or 
minimal impact to their QOL (a sum score of 42 or less on the first 28 questions of 
the QLQ-C30), while six experienced a moderate-to-large impact on QOL (a sum score 
of 56 or greater). The most commonly reported items were Question 10 “Did you 
need rest?”, Question 18 “Were you tired?”, and Question 22 “Did you worry?” with 
22, 25, and 22, participants, respectively, noting concerns. This also was a common 
concern of individuals with HNCa reported in a study by Capra et al. (2001). However, 
for symptoms reported to be experienced “Very much” within the present 
investigation, there was wide variation. Participants reported a symptom as “Very 
much” a concern 34 times, with 19 different items on the QLQ-C30 being selected at 
least once. The individualized nature of how nutritional status in influenced over the 
course of HNCa therapy has been outlined in various other studies utilizing 
hospitalized patients (Arends et al., 2016; Capra et al., 2001; Larsson et al., 2005). 
This variability also being present in outpatient makes it difficult to identify which 
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areas one should target to improve the QOL of this population. The best approach 
seems to be to individualize therapies to identify and address those factors having 
the greatest negative influence on QOL. 
 What became apparent once nutrition status was brought into consideration 
was that the majority of symptoms reported as “Very much” a concern had been 
reported by nutritionally compromised individuals (28 of the 34). Furthermore, 
whenever a significant difference was observed between the means of reported 
items it was the nutritionally compromised group which presented with the greater 
QOL concern. A similar trend was observed when participants rated their personal 
health and Global QOL status. The nutritionally compromised individuals continued 
to indicate lower mean scores for these domains. This suggests that a correlation 
existed between nutrition status and a worse perceived personal health and Global 
QOL status in the present investigation, a finding that agrees with past reports 
(Silander, Nyman & Hammerlid, 2013). However, as this is a correlational assessment 
it is difficult to determine if nutrition status is what is causing lower perceptions of 
health and Global QOL, or vice versa. Further research is needed in order to 
investigate the direction of this correlation.  
 Another interesting finding was that a similar pattern became apparent when 
the participant functional domain scores were observed. That is, for every functional 
domain assessed by the QLQ-C30, the mean scores of the nutritionally compromised 
group were lower, with the “Physical”, “Social”, and “Cognitive” domains all reaching 
significance. The finding that functionality is increasingly impaired with declining 
nutrition status agrees with past studies (Farhangfar et al., 2014; Kubrak et al., 2013). 
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Overall, when comparing perceived personal “functional status” in the present 
investigation, those comprising the nutritionally compromised group judged their 
functioning to be worse. This pattern held true for all the symptom domains as well, 
with one exception (diarrhea) which was not significant. The nutritionally 
compromised individuals indicated that they were experiencing these symptoms to a 
higher degree with “fatigue”, “appetite loss”, and “constipation” reaching 
significance. This finding that greater symptom burden was associated with greater 
nutritional concerns also agrees with past literature (Capuano et al., 2010; Farhangfar 
et al., 2014; List et al., 1997; Reeve et al., 2016). The cumulative effects of a greater 
symptom burden and lower perceived functional status may offer a partial 
explanation for the lower Global QOL domain scores reported by the nutritionally 
compromised individuals in the present study. Overall, the data suggest that 
nutrition status of HNCa outpatients is associated with their functionality, symptom 
burden, and perceived health and Global QOL. This illustrates the importance of 
nutrition care practices such as screening.  
Results of the EORTC QLQ-H&N35   
 
 The EORTC QLQ-H&N35 module was designed specifically for individuals with 
HNCa. As was the case with the EORTC QLQ-C30, though the majority of participants 
reported experiencing a subset of the symptoms, individual experiences varied. Some 
participants (n = 19) experienced none or minimal impact to their QOL (determined 
by a sum score of 52 or less), while a few others (n = 7) experienced a moderate-to-
large impact on QOL (a score of >70). The most commonly reported symptoms on the 
H&N35 were Question 15 “Have you coughed?”  and Question 11 “Did you have a 
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dry mouth?” (n= 21 and 20, respectively). Additionally, the symptom which was most 
commonly reported as “Very much” a concern was Question 7 “Have you had trouble 
swallowing solid food?” (n=5). The high prevalence of dry mouth and swallowing 
problems reported in the present cohort agrees with past literature on others with 
HNCa (Chasen & Bhargava, 2009; Larsson et al., 2005). These observations highlight 
the need for the implementation of routine nutrition screening practices as it is clear 
that these nutrition symptoms are present in those treated for HNCa. Furthermore, 
various differences were once again observed between the mean scores of individual 
items reported by the nutritionally compromised and well-nourished groups. In every 
instance a significant difference was observed it was the nutritionally compromised 
who had reported the greater QOL concern. This suggests that those who were 
nutritionally compromised at the time of the study also reported greater QOL 
impacts based on the QLQ-H&N35, a finding supported by past literature (Silander et 
al., 2013). Thus, efforts which aim to address the nutrition related concerns of 
individuals with HNCa through nutrition screening could identify and address these 
issues which may result in appreciable benefits for health and QOL. 
 EORTC QLQ-H&N35 domain scores produced similar results to those of the 
QLQ-C30 in regards to the differences between the well-nourished and nutritionally 
compromised groups. The nutritionally compromised group reported greater QOL 
concerns for all symptom domains with exception of “Pain”, “Nutritional 
supplementation” and “Weight gain” none of which reached significance. To explain 
these findings, it could be assumed that nutritional supplements would help 
individuals remain well-nourished and thus retain, or possibly even gain, weight. 
Despite debate, the benefit of nutritional supplementation, has positively influenced 
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weight retention in individuals with cancer (Baldwin & Weekes, 2012). Additionally, 
the experience of pain was possibly a greater concern for the well-nourished group 
because the use of pain-killers was much more common among the nutritionally 
compromised group. Domains reaching significance included “senses” and “speech 
problems”, “teeth”, and “dry mouth”. These significant findings for our outpatient 
cohort agree with past findings regarding the common concerns of hospitalized 
patients with HNCa (Alshadwi et al., 2013; Chasen & Bhargava, 2009; Hayward & 
Shea, 2009; Larsson et al., 2005). Overall, for the majority of these QOL symptoms, 
the nutritionally compromised group perceived that they were experiencing them to 
a greater extent. This again warrants efforts targeting the nutritional concerns of 
outpatients treated for HNCa as doing so could mitigate their effects and result in 
QOL improvements.  
 In summary, data obtained from the QLQ-C30 and H&N35 demonstrate that a 
significant variability exists among individuals with HNCa in regard to their 
perception of nutrition status, functionality and QOL. Possibly the most important 
finding for the present study was the differences identified between the well-
nourished and nutritionally compromised groups. These results suggest that there is 
an association between the incidence of a poor nutrition status and the experience 
of a worse functionality and QOL for outpatients with HNCa.  
Consistency of Responses  
 
The present data illustrate a correlation between participant’s responses for 
the QOL, nutrition measures, and functional and symptom domain scores. When 
individuals reported a lower perceived QOL, they also tended to present with poorer 
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nutrition scores and worse functional and symptom domain scores. This suggests 
that those participants who were experiencing greater nutrition related concerns 
also tended to experience a greater symptom burden, worse functionality and a 
lower perceived health and Global QOL status. 
Correlational Analysis 
 
The domains selected for the correlational analysis were those which were 
thought to, or have proven in the past to, retain a potential to influence nutrition 
status (Farhangfar et al., 2014; Kubrak et al., 2010). This resulted in the inclusion of 
Global QOL scores, the five functional domain scores, and 12 of the 27 “symptom” 
domain scores from each of the EORTC QLQ-C30 and H&N35 in addition to the 
nutrition scores recorded by the PG-SGA nutrition assessment. This correlational 
analysis revealed a number of moderate positive and negative relationships which 
are remarkable. First, a moderate inverse relationship was found between the Global 
QOL domain and the nutrition scores obtained from the PG-SGA nutrition 
assessment. This suggests that with higher nutrition related concerns QOL decreases 
(Silander et al., 2013). This illustrates that, at least in part, QOL is influenced 
negatively by a declining nutritional status.  
Next, moderate relationships were also discovered to exist among the PG-
SGA nutrition scores, Global QOL and the physical, cognitive and social functioning 
domain scores. The presence of these relationships suggests that as nutritional status 
worsens, functional ability may decline (Farhangfar et al., 2014; Kubrak et al., 2013). 
This is a logical conclusion given that a declining nutrition status may decrease one’s 
social functioning as they no longer desire to eat with friends and family (Penner, 
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2009). Worse nutrition status also has the potential to result in increased tiredness 
which can negatively influence physical and cognitive functioning (Capuano et al., 
2010; Ma et al., 2013). Conversely, the reverse could also be true and a reduced 
functional status could be resulting in a declining nutrition status. Despite the 
precipitating factor being difficult to identify, it is evident that many interrelated 
factors are influencing the nutrition status, functionality, and Global QOL of 
individuals with HNCa. 
Next, when evaluating the correlations present between the PG-SGA 
assessment scores and the individual symptom scores of the EORTC QLQ-C30 and 
H&N35 various moderate associations were identified. The symptoms identified as 
being most strongly correlated with PG-SGA scores were “Senses problems”, r(32) 
=0.6, p<0.01, “Appetite loss”, r(32) = 0.58, p<0.01, and “Constipation”, r(32) = 0.56, 
p<0.01. These three symptom domains also had moderate-to-strong correlations 
with Global QOL and subsets of the functional domains. This suggest that as 
individuals experience these symptoms to a higher degree, it becomes more likely 
that their nutritional status will decline along with their perception of their Global 
QOL and functionality (). These findings are not unexpected, individuals with cancer 
commonly experience these types of symptoms which can influence QOL (Capuano 
et al., 2010; Farhangfar et al., 2014; Gorenc et al., 2015; List et al., 1997; McQuestion, 
2006; Reeve et al., 2016). Efforts attempting to identify and address these types of 
short- and long-term nutritional concerns could result in improvements for nutrition 
status, functionality, and the perceived health and QOL of individuals with HNCa.  
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Supplemental Observational Analysis 
 
 Multiple relationships present within this investigation may offer useful 
insights into how the nutrition status of outpatient individuals with HNCa may be 
influenced. However, it must be noted that the experiences of individuals within the 
present study varied significantly. Thus, supplemental analyses of the data were 
completed in order to consider further influences on participant nutrition status. 
 First a visual examination of potential trends related to treatment modality 
were considered. As HNCa can occur at a variety of different sites and stages, the 
treatment options also vary. T-tests were performed to assess the data across the 
different treatment modality categories which suggested that individuals who had 
received surgery alone retained a better nutrition status (t(33)=2.75, p<0.01), as well 
as a better Global QOL (t(33)=3.95, p<0.001). An assessment of time-post treatment 
revealed no significant relationships with treatment type, nutrition, or QOL scores, a 
finding which diverges from past studies (Tong et al., 2009). Thus, time-post 
treatment did not provide an explanation for these observed trends in the present 
study, suggesting that treatment modality influenced both nutrition status and QOL. 
This is not an unexpected finding as it has been reported in past studies that surgery 
tends to have less severe impacts on nutrition than alternative treatment modalities 
(Arends et al., 2016; Van Cutsem & Arends, 2005).  
 Next, the influence of smoking status on nutrition status was explored as 
tobacco consumption is known to influence appetite (Alshadwi et al., 2013). 
Statistical analysis revealed the mean nutrition scores of non-smokers and the 
combined group of current and past smokers differed significantly (t(33)=2.58, 
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p<0.05). Non-smokers presented with lower nutritional concerns, a finding which 
agrees with past literature (Haghjoo, 2015). It was interesting however, that former 
smokers presented with higher nutrition scores than current tobacco users. This 
finding is possibly related to the former smoker’s tendency to have longer histories of 
tobacco use which may result in greater, long-lasting, nutritional compromise.  
 Finally, the influence of age on nutrition status was examined as nutrition-
related concerns tend to become more common as one ages (Stratton & Elia, 2005). 
Data in the present investigation supported this, illustrating that nutritional concerns 
increased with age, r(32)=0.48, p<0.01. However, the correlation between age and 
QOL scores was insignificant. This suggests that despite increasing nutrition-related 
complications with age, individual participants were not necessarily perceiving 
corresponding declines in their QOL with age. Thus, perceived QOL may not be a 
strong indication of nutritional concerns. This justifies the implementation of routine 
nutrition screening in order to identify and proactively manage the nutritional 
concerns of individuals with HNCa, mitigating their negative effects. 
Summary  
 
 The results of this preliminary study suggest that PG-SGA SF and Pt-Global 
Application can serve as self-administered nutrition screens. Both instruments could 
potentially be utilized as effective first steps in the nutrition care pathway for 
outpatients with HNCa. Thus, both tools deserve to be investigated further regarding 
their ability to be administered on a routine basis in healthcare settings. Currently, 
the PG-SGA SF is preferred over the Pt-Global Application by the outpatient HNCa 
population. This however, could change as comfort levels utilizing electronic 
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applications increase. The findings from the present investigation also illustrated that 
nutrition status is indeed influenced by HNCa and its treatment on an individualized 
basis. These impacts on nutrition status can have significant corresponding impacts 
on individual Global QOL. Further, a worse nutrition status was found to be 
associated with a lower perceived functional ability, as well as an increased symptom 
burden. Finally, the data also suggest that nutrition status may be influenced by 
factors such as treatment modality, smoking status, and age. These findings illustrate 
the importance of nutrition care practices from a QOL perspective and provide 
justification for the implementation of routine nutrition screening in the outpatient 
HNCa population.  
Clinical implications 
 
The frequent failure to recognize and treat malnutrition in populations where 
it is a common concern, such as for those with HNCa, has been stated as being 
unacceptable (Elia et al., 2005). Early identification of malnutrition in those treated 
for HNCa would enable early intervention and present a tremendous opportunity to 
reduce weight loss, healthcare costs, treatment complications, hospital readmissions, 
mortality and morbidity rates, improve performance status, clinical outcomes, overall 
care and QOL (Capuano et al., 2010; Isenring et al., 2004; Tappenden et al., 2013). 
However, for these benefits to become a reality, nutrition status must be regularly 
assessed and the appropriate interventions must be provided. Proactive approaches 
to nutrition management tend to be more successful than approaches delayed until 
later stages of excessive weight loss (Baldwin & Weekes, 2012; Isenring et al., 2007; 
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Langius et al., 2016; Ravasco et al., 2008;). Until nutritional evaluations become 
routine, proactive solutions addressing nutritional concerns will likely remain evasive.  
In the present study the PG-SGA SF achieved acceptable levels of accuracy 
and reliability, supporting its potential to be used as a nutrition screening tool in the 
HNCa outpatient population. The Pt-Global Application did achieve acceptable levels 
of specificity, however, more work must be done to improve the sensitivity of the 
tool or comfort levels using electronic applications must increase if this nutrition 
screening tool is to be used effectively. If these changes occur, the Pt-Global 
Application could potentially streamline the nutrition screening process.  
Thus, either of the current PG-SGA SF or an improved version of the Pt-Global 
Application, if proven reliable, could be implemented in clinical practice. 
Implementation of these nutrition screens may enable the efficient and accurate 
identification of those at nutritional risk who may require further comprehensive 
nutrition assessments. Similarly, findings from such screening may also serve to 
reduce unnecessary referrals. This would yield many benefits such as increased 
efficiency, timely access to information, safety, improved healthcare as well as 
significantly reduce healthcare expenses (David et al., 2013). Additionally, as the PG-
SGA SF and Pt-Global Application can be utilized as self-administered measurements, 
they overcome many challenges and limitations associated with current screening 
tools such as limited time and financial resources (Abbott et al., 2014; Santarpia et 
al., 2011).  
Overall, the findings of the present study indicate that self-administered 
nutrition screens are viable options for addressing the nutrition related concerns of 
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HNCa outpatients. Thus, the use of screening to identify nutrition concerns appears 
justified and investigations into the implementation of efficient screening tools has 
been suggested (Cawood et al., 2012; Kondrup et al., 2003). As nutrition concerns are 
common and costly side-effects of HNCa treatment which take significant time to 
address, screening and addressing them proactively could reduce costs spent 
addressing them at later stages of treatment (Abizanda et al., 2016; Baracos, 2006; 
Prevost et al., 2014). Thus, nutrition screening may yield benefits for individual 
health and QOL as well as the healthcare system. 
Limitations of Present Study 
 
 Certain limitations exist relative to the present study. The first is sample size. 
Given the relatively limited number of participants, casual conclusions cannot be 
made regarding the changes to nutrition status following a diagnosis and treatment 
for HNCa. Additionally, only a single recruitment site was utilized in the present 
study, a surgical clinic. Thus, results cannot be generalized to participants diagnosed 
and treated at different locations as the patient population, the type of treatment 
services and the quality of those provided services may differ at a separate location. 
Also, as participants in this study performed self-assessments on both the nutrition 
screens and the QOL instruments, it is possible that participant bias was present in 
how they perceived and reported their health, QOL and nutrition status. Recall bias is 
always a concern when participants are asked to report on past behaviours. Finally, 
data were only collected from participants who were between three months post-
diagnosis to two years post-treatment. Thus, it is possible that the data does not 
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capture the full experience of individuals with HNCa given the variability of treatment 
side-effects and potential longer-term issues. 
 The demographic variability of the study population presents a further 
limitation. Participants varied across demographic variables and various subgroups of 
patients existed, each characterized by their own unique variability. Such variability 
prevents generalized claims from being made due to the mediating or moderating 
factors accompanying each of these unique circumstances. This limitation could be 
addressed by increasing the number of participants and identifying homogenous sub-
groups. The increased homogeneity would enable more accurate assessments of 
factors influencing the nutrition status of outpatient individuals with HNCa by 
minimizing the effects of mediating and moderating factors. Determining how these 
factors influence the nutrition of individuals with HNCa may provide insights for 
future investigations on self-administered nutrition screens. 
Directions for Future Research 
 
 Though the absence of a universal definition for malnutrition in the HNCa 
population from which nutrition evaluations and interventions can be based remains 
an issue, this should not discourage future efforts that seek to address nutritional 
concerns (Cushen et al., 2015). This study provided a strong justification for the 
routine use of nutrition screening tools in the healthcare system. It has provided a 
starting point for research that seeks to assess how instruments such as the PG-SGA 
SF and Pt-Global Application might be used over the course of the diagnosis, 
treatment, and follow-up. Though, the topic of nutrition status in oncology is gaining 
increasing recognition, limited information exists on the use self-administered 
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nutrition screens in the area of HNCa and the majority of work currently completed 
focuses on hospitalized individuals. Continued research into how these types of 
instruments might be used in clinical settings is important (Cawood et al., 2012; 
Kondrup et al., 2003). The efficient implementation of such tools could help mitigate 
the consequences associated with the treatment of HNCa, decrease post-treatment 
complications, optimize rehabilitation efforts, and reduce the workloads of 
healthcare professionals (Cawood et al., 2012; David et al., 2013). 
Future research might assess the impact of altering threshold scores of the 
self-administered nutrition screens used in this study in order increase their accuracy 
ratings. Additional research might also be performed assessing the ability of the Pt-
Global Application as a self-administered nutrition screen to be completed over the 
internet as this tool is application based. Examinations into the compliance of 
individuals to complete the Pt-Global Application online and the reliability of these 
screens could therefore be targeted in future studies.  
Though it is unlikely that the nutritional concerns associated with HNCa 
treatment can be completely eliminated, understanding which factors have the 
greatest influence on nutrition status and how an impaired nutrition status 
influences functionality may provide valuable information moving forward. This 
information may guide targeted therapies for nutritional concerns, resulting in 
reductions in healthcare expenses as well as QOL and health status improvements.  
Overall, the primary goal of continuing research into self-administered 
nutrition screening tools in the HNCa population is to find an instrument which 
achieves acceptable rates of sensitivity and specificity in order to justify its routine 
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implementation. Such a tool would enable proactive identification of nutritional 
concerns while also transferring the responsibility of completing these screens from 
busy healthcare professionals to the individual (Cawood et al., 2012; David et al., 
2013).  
Conclusions 
 
 Though treatments for individuals diagnosed with cancers continue to 
improve, these individuals still face an array of treatment-related consequences. 
Decreases in functional abilities and QOL are among some of the most common 
outcomes associated with cancer treatments (Ma et al., 2013; Sherman et al., 2000). 
Treatment for HNCa is no exception. Though treatment methods vary due to the 
heterogeneity of this cancer, they often retain the potential to have psychosocial and 
physical impacts on the individuals being treated (Penner, 2009). These impacts can 
result in a diminishing nutrition status for individuals diagnosed and treated for HNCa 
and this was supported by the findings of this initial study. The data collected suggest 
that compromised nutrition status remains a common concern for those treated for 
HNCa. Further, the findings of the present study agree with past literature that 
nutrition status can be influenced by many variables such as treatment modality (Van 
Cutsem & Arends, 2005), smoking status (Hall et al., 2000; Reeve et al., 2016), and 
age (Stratton & Elia, 2005).  
The findings of the present investigation suggest that nutrition screening 
could help to proactively identify nutritional concerns of outpatients with HNCa. As 
healthcare professionals are already experiencing heavy workloads, measurements 
which can effectively and reliably be utilized for self-screening are desirable and have 
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been called for (Cawood et al., 2012). The findings from this study support this 
method of self-screening nutrition status as a viable option with paper-based 
screening tools currently being the preferred mode of delivery. Given that diminished 
nutrition status is associated with an array of negative implications for treatment 
outcomes and the rehabilitation process, the use of self-administered nutrition 
screening tools, such as the PG-SGA SF and the Pt-Global Application may provide a 
cost-effective solution. Such instruments would proactively identify nutrition-related 
concerns while also lessening the burden experienced by healthcare professionals. 
This could yield benefits for the health and QOL of HNCa outpatients (Capuano et al., 
2010; Isenring et al., 2004; Tappenden et al., 2013). Thus, continued efforts exploring 
these crucial concepts are warranted due to the potential for both short- and long-
term improvements in patient care, treatment outcomes, and QOL.  
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APPENDIX B 
                                                                                                                
Laboratory for Well-Being and Quality of life in Oncology University of Western Ontario 
 
Letter of Information 
 
Principal Investigators: Philip C. Doyle, Ph.D., Mark J.P. Lynch, M.Sc., Julie A. Theurer, Ph.D. 
 
Project Title: “The application of self-administered nutrition screening tools and evaluations 
of the impact of malnutrition on quality of life in individuals with head and neck cancer” 
 
Purpose of the study 
The purpose of this letter is to provide you with information required for you to make an 
informed decision regarding participation in this research. This study will examine the ability 
of up to 100 individuals with head and neck cancer to self-screen their nutrition status, as 
well as how nutrition status relates to quality of life in this population. This study will identify 
if individuals with head and neck cancer have an ability to reliably self-screen nutrition 
status; this may give this group a more direct and active role in their treatment and help 
professionals understand their nutrition status. Parts of this study represent a Master’s 
thesis project for one of the investigators (ML). 
 
Activities of participants 
If you agree to participate, you will complete a general demographic information survey 
(e.g., age, gender, etc.). You will then complete two nutrition status self-screens (PG-SGA SF 
& Pt-Global App) as well as an ease-of-use questionnaire. During this visit, you will also 
complete two quality of life questionnaires (EORTC-QLQ-C30 & EORTC-QLQ-HN35). 
Information gathered from each survey and questionnaire will be coded so that your identity 
remains confidential. Following this you will then undergo a brief non-invasive physician 
administered examination for the PG-SGA nutrition assessment. The remaining information 
for completion of the nutrition assessment shall be gathered by the researcher from patient 
charts. The entire procedure (questionnaire completion, nutrition screen and nutrition 
assessment) will take place in a quiet clinic room at the London Health Sciences Centre and 
should take less than 20 minutes. 
 
Exclusion Criteria 
You will be excluded from participating in the study if you are younger than 30 or older than 
80 years of age. Individuals with skin cancers shall be excluded as these types of cancers 
should not increase the risk of nutritional decline. Participants unable to read or speak 
English will be excluded as these individuals would struggle to complete the tasks necessary 
for this study. For similar reasons participants with severe physical disabilities, dementia or 
other obvious cognitive impairments, or if their vision does not permit them to see the 
questionnaires shall also be excluded. 
 
Possible risks involved 
There are no known risks or discomforts associated with participation in this research study. 
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Participation is voluntary. You may refuse to participate, refuse to answer any questions or 
perform any part nutrition screens or nutrition assessment, or withdraw from the study at 
any time. You do not waive any legal rights by signing the consent form. Finally, withdrawal 
from the study will in no way influence your continuing medical care. There is no discomfort 
with either the nutrition screens or nutrition assessment. 
 
Possible benefits involved 
Due to the nature of this study, you will not directly benefit from the data obtained and you 
will not be compensated for your participation in this research. We would, however, be happy 
to share the results of our findings with you should you desire. 
 
Voluntary Participation 
Participation in this study is voluntary and you may refuse to participate, refuse to answer 
any questions or withdraw from the study at any time. Doing so will have no effect on your 
current or future medical care. By signing the consent form to participate within this study 
you do not waive any legal rights. 
 
Confidentiality 
All data collected will remain confidential to the best of our ability. Your data will be 
identified by a code known only to the investigators. If the results are published, your name 
will not be used. If you choose to withdraw from this study, your data will be removed and 
destroyed from our database. It is also a possibility that qualified representatives from 
Lawson Quality Assurance Education Program and University of Western Ontario Health 
Sciences Research Ethics Board may look at participants’ records for quality assurance. 
 
 
Contacts for further questions 
If you require any further information regarding this research project or your participation in 
the study, please feel free to contact: 
 
Philip Doyle, Ph.D. or Mark J.P. Lynch, M.Sc. 
Laboratory for Well-Being and Quality of Life in Oncology, Rehabilitation Sciences Elborn 
College, University of Western Ontario, London, Ontario N6G 1H1 
519-661-2111 ext. 88942  pdoyle@uwo.ca mlynch47@uwo.ca 
 
If you have any questions about your rights as a research participant or the conduct of this 
study, you may contact: 
David Hill, FCAHS 
Lawson Health Research Institute Director and Integrated Vice President, Research for 
London Health Sciences Centre and St. Joseph’s Health Care London 
519-646-6100 ext. 64716 
 
Western University, The Office of Human Research Ethics 
Room 5150 Support Services Building, 1393 Western Road, London, Ontario, Canada, 
N6G1G9 Tel: RDS: 519-661-2161 | Research Ethics: 519-661-3036 
ethics@uwo.ca 
This letter is for you to keep. 
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APPENDIX C 
Demographic Information Survey 
 
Title: “The application of self-administered nutrition screening tools and evaluations of the 
impact of malnutrition on quality of life in individuals with head and neck cancer” 
 
Study Investigators: Philip Doyle, Ph.D., Mark Lynch, B.H.Sc., M.Sc. (Candidate), Julie 
Theurer, Ph.D.  
 
Please read the following questions carefully and provide answers as accurately as possible. 
For multiple choice options, please circle all choices that apply to you. If no suitable options 
exist, please use the space provided to explain. Also, if there is any additional information 
that you feel is important to report regarding your body image or perceived QOL, please use 
the back of these pages to include it.   
 
Sex: M / F / Other  
 
Age: ____________ Year of Birth: ___________  
 
Month of Birth: ___________ Number of months since your diagnosis: _____________  
 
What is your current treatment status? 
 
a) Currently waiting for treatment 
b) Currently undergoing treatment 
c) Completed treatment 
 
Site of Cancer:  
 
a) Oral cavity (e.g., lip, tongue, cheek, tonsil, etc.)  
b) Larynx (voice box)  
c) Throat (e.g., pharynx, hypopharynx, oropharynx)  
d) Thyroid  
e) Sinuses/Paranasal sinuses  
f) Other  
 
If “other”, please specify: 
____________________________________________________________________  
 
 
Method of Treatment:  
 
a) Surgery  
b) Radiation therapy  
c) Chemotherapy  
d) Chemoradiation therapy  
e) Other  
 
If “other”, please specify: 
____________________________________________________________________  
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Marital Status (circle one):  
 
a) Married  
b) Separated  
c) Divorced  
d) Widowed  
e) Common-law  
f) Engaged  
g) Single  
h) Other  
 
If “other”, please specify: 
____________________________________________________________________  
 
Occupational Status:  
 
a) Currently working – full-time  
b) Currently working – part-time  
c) Volunteer  
d) Retired  
e) Other  
 
If “other”, please specify: 
____________________________________________________________________  
 
Highest Level of Education Achieved:  
 
a) Less than high school 
b) Some high school 
c) Completed High school  
d) Some college/post secondary 
e) Completed college/post-secondary 
f) Apprenticeship 
g) Trade school  
c) Undergraduate University degree (i.e., Bachelor’s degree) 
d) Post-graduate University degree (i.e., Master’s degree, Doctorate)  
e) Other  
 
If “other”, please specify: 
____________________________________________________________________  
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Tobaccos use status: 
 
a) Currently use tobacco products 
b) Formerly used tobacco products 
c) Never used tobacco products 
 
If you currently use, or used tobacco products, approximately what quantity of what product 
(e.g., cigarettes, chewing tobacco, cigars, etc.) do/did you consume in an average week? 
_______________________________________________________________________ 
 
Alcohol use status: 
 
a) Currently consume alcohol 
b) Formerly consumed alcohol 
c) Never consumed alcohol 
 
If you currently consume, or used to consume alcohol, approximately how many beverages 
do/did you consume in an average week? _______________________________________ 
 
 
Household income (optional): 
 
a) Less than $25,000 
b) $25,000 - $50,000 
c) $50,001 - $ 75,000 
d) Greater than $75,000 
e) Would prefer not to say  
 
 
Please feel free to include any additional information that you feel is important specific to 
this project in the space provided below or on the opposite side of this document. Thank 
you.  
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
________________________________________________ 
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APPENDIX D 
 
EORTC QLQ-C30 (version 3) 
 
We are interested in some things about you and your health. Please answer all of the questions yourself 
by circling the number that best applies to you. There are no "right" or "wrong" answers. The information 
that you provide will remain strictly confidential. 
 
Please fill in your initials:                                  
Your birthdate (Day, Month, Year):                
Today's date (Day, Month, Year):                   
 
  
Not at 
All 
 
A  
Little 
 
Quite 
a Bit 
 
Very 
Much 
1. Do you have any trouble doing strenuous activities,     
 like carrying a heavy shopping bag or a suitcase? 1 2 3 4 
 
2. 
 
Do you have any trouble taking a long walk? 
 
1 
 
2 
 
3 
 
4 
 
3. 
 
Do you have any trouble taking a short walk outside of the house? 
 
1 
 
2 
 
3 
 
4 
 
4. 
 
Do you need to stay in bed or a chair during the day? 
 
1 
 
2 
 
3 
 
4 
 
5. 
 
Do you need help with eating, dressing, washing 
    
 yourself or using the toilet? 1 2 3 4 
 
 
During the past week: Not at 
All 
A Little Quite a 
Bit 
Very 
Much  
6. 
 
Were you limited in doing either your work or other daily 
activities? 
 
1 
 
2 
 
3 
 
4 
 
7. 
 
Were you limited in pursuing your hobbies or other leisure 
time activities? 
 
 
1 
 
 
2 
 
 
3 
 
 
4  
8. 
 
Were you short of breath? 
 
1 
 
2 
 
3 
 
4 
 
9. 
 
Have you had pain? 
 
1 
 
2 
 
3 
 
4 
 
10. 
 
Did you need to rest? 
 
1 
 
2 
 
3 
 
4 
 
11. 
 
Have you had trouble sleeping? 
 
1 
 
2 
 
3 
 
4 
 
12. 
 
Have you felt weak? 
 
1 
 
2 
 
3 
 
4 
 
13. 
 
Have you lacked appetite? 
 
1 
 
2 
 
3 
 
4 
 
14. 
 
Have you felt nauseated? 
 
1 
 
2 
 
3 
 
4 
 
15. 
 
Have you vomited? 
 
1 
 
2 
 
3 
 
4 
 
16. 
 
Have you been constipated? 
 
1 
 
2 
 
3 
 
4 
 
Please go on to the next page
   
125 
 
 
 
 
 
During the past week: Not at 
All 
  A  
Little 
Quite  
a Bit 
Very 
Much 
 
17. 
 
Have you had diarrhea? 
 
1 
 
2 
 
3 
 
4 
 
18. 
 
Were you tired? 
 
1 
 
2 
 
3 
 
4 
 
19. 
 
Did pain interfere with your daily activities? 
 
1 
 
2 
 
3 
 
4 
 
20. 
 
Have you had difficulty in concentrating on things, like 
reading a newspaper or watching television? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
21. 
 
Did you feel tense? 
 
1 
 
2 
 
3 
 
4 
 
22. 
 
Did you worry? 
 
1 
 
2 
 
3 
 
4 
 
23. 
 
Did you feel irritable? 
 
1 
 
2 
 
3 
 
4 
 
24. 
 
Did you feel depressed? 
 
1 
 
2 
 
3 
 
4 
 
25. 
 
Have you had difficulty remembering things? 
 
1 
 
2 
 
3 
 
4 
 
26. 
 
Has your physical condition or medical treatment 
interfered with your family life? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
27. 
 
Has your physical condition or medical treatment 
interfered with your social activities? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
28. 
 
Has your physical condition or medical treatment 
caused you financial difficulties? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
For  the  following  questions  please  circle  the  number  between  1  and  7  that best applies 
to you 
 
29.    How would you rate your overall health during the past week? 
 
1                2                3                4                5                6                   7 
 
Very poor                                                                                                     Excellent 
 
 
 
30.    How would you rate your overall quality of life during the past week? 
 
1                2                3                4                5                6                   7 
 
Very poor                                                                                                     Excellent 
 
 
 
 
© Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0 
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APPENDIX E 
  
EORTC  QLQ - H&N35 
 
 
 
Patients sometimes report that they have the following symptoms or problems. Please indicate 
the extent to which you have experienced these symptoms or problems during the past week. 
Please answer by circling the number that best applies to you. 
 
 
During the past week: 
 
Not at all 
 
A 
little 
 
Quite a 
bit 
 
Very 
much 
 
31. 
 
Have you had pain in your mouth? 
 
1 
 
2 
 
3 
 
4 
 
32. 
 
Have you had pain in your jaw? 
 
1 
 
2 
 
3 
 
4 
 
33. 
 
Have you had soreness in your mouth? 
 
1 
 
2 
 
3 
 
4 
 
34. 
 
Have you had a painful throat? 
 
1 
 
2 
 
3 
 
4 
 
35. 
 
Have you had problems swallowing liquids? 
 
1 
 
2 
 
3 
 
4 
 
36. 
 
Have you had problems swallowing pureed food? 
 
1 
 
2 
 
3 
 
4 
 
37. 
 
Have you had problems swallowing solid food? 
 
1 
 
2 
 
3 
 
4 
 
38. 
 
Have you choked when swallowing? 
 
1 
 
2 
 
3 
 
4 
 
39. 
 
Have you had problems with your teeth? 
 
1 
 
2 
 
3 
 
4 
 
40. 
 
Have you had problems opening your mouth 
wide? 
 
1 
 
2 
 
3 
 
4 
 
41. 
 
Have you had a dry mouth? 
 
1 
 
2 
 
3 
 
4 
 
42. 
 
Have you had sticky saliva? 
 
1 
 
2 
 
3 
 
4 
 
43. 
 
Have you had problems with your sense of smell? 
 
1 
 
2 
 
3 
 
4 
 
44. 
 
Have you had problems with your sense of taste? 
 
1 
 
2 
 
3 
 
4 
 
45. 
 
Have you coughed? 
 
1 
 
2 
 
3 
 
4 
 
46. 
 
Have you been hoarse? 
 
1 
 
2 
 
3 
 
4 
 
47. 
 
Have you felt ill? 
 
1 
 
2 
 
3 
 
4 
 
48. 
 
Has your appearance bothered you? 
 
1 
 
2 
 
3 
 
4 
 
 
Please go on to the next page
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During the past week: Not at 
all 
A 
little 
Quite 
 a bit 
Very 
much 
 
49. 
 
Have you had trouble eating? 
 
1 
 
2 
 
3 
 
4 
 
50. 
 
Have you had trouble eating in front of your family? 
 
1 
 
2 
 
3 
 
4 
 
51. 
 
Have you had trouble eating in front of other people? 
 
1 
 
2 
 
3 
 
4 
 
52. 
 
Have you had trouble enjoying your meals? 
 
1 
 
2 
 
3 
 
4 
 
53. 
 
Have you had trouble talking to other people? 
 
1 
 
2 
 
3 
 
4 
 
54. 
 
Have you had trouble talking on the telephone? 
 
1 
 
2 
 
3 
 
4 
 
55. 
 
Have you had trouble having social contact with your 
family? 
 
1 
 
2 
 
3 
 
4 
 
56. 
 
Have you had trouble having social contact with friends? 
 
1 
 
2 
 
3 
 
4 
 
57. 
 
Have you had trouble going out in public? 
 
1 
 
2 
 
3 
 
4 
 
58. 
 
Have you had trouble having physical contact with family 
or friends? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
59. 
 
Have you felt less interest in sex? 
 
1 
 
2 
 
3 
 
4 
 
60. 
 
Have you felt less sexual enjoyment? 
 
1 
 
2 
 
3 
 
4 
 
 
 
 
61. 
During the past week: 
 
Have you used pain-killers? 
No 
 
1 
Yes 
 
    2  
62. 
 
Have you taken any nutritional supplements (excluding vitamins)? 
 
1 
 
    2 
 
63. 
 
Have you used a feeding tube? 
 
1 
 
    2 
 
64. 
 
Have you lost weight? 
 
1 
 
    2 
 
65. 
 
Have you gained weight? 
 
1 
 
    2 
 
 
 
 
 
 
 
© Copyright 1994 EORTC Quality of Life Study Group, version 1.0 All rights reserved  
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131 
 
APPENDIX H 
Ease of use form 
Initials: 
Age: 
Gender: 
For each item identified below, circle the number to the right  of each question that best 
describes your level of agreement with the statement.  
Survey Item 
Strongly 
Disagree 
Disagree Undecided Agree 
Strongly 
Agree 
1. The PG-SGA SF is easy to use. 1 2 3 4 5 
2. The PG-SGA SF is organized in a way 
that is easy to understand. 
1 2 3 4 5 
3. The items and questions asked on the 
PG-SGA SF were simple and easy to 
understand. 
1 2 3 4 5 
4. The PG-SGA SF can be completed 
quickly and easily without the aid of a 
professional. 
1 2 3 4 5 
5. The PG-SGA SF was a simple tool for 
assessing my own nutrition status.  
1 2 3 4 5 
6. The Pt-Global App is easy to use. 1 2 3 4 5 
7. The Pt-Global App is organized in a way 
that is easy to understand. 
1 2 3 4 5 
8. The items and questions asked on the 
Pt-Global App were simple and easy to 
understand. 
1 2 3 4 5 
9. The Pt-Global App can be completed 
quickly and easily without the aid of a 
professional. 
1 2 3 4 5 
10. The Pt-Global App was a simple tool for 
assessing my own nutrition status.  
1 2 3 4 5 
11. If you experienced any difficulties using 
the PG-SGA SF please list them to the 
right along with any suggestions for 
improvement.  
 
12. If you experienced any difficulties using 
the Pt-Global App please list them to 
the right along with any suggestions for 
improvement. 
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